BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shaheen NJ, Sharma P, Overholt BF, Wolfsen HC, Sampliner RE, Wang KK, Galanko JA, Bronner MP, Goldblum JR, Bennett AE, Jobe BA, Eisen GM, Fennerty MB, Hunter JG, Fleischer DE, Sharma VK, Hawes RH, Hoffman BJ, Rothstein RI, Gordon SR, Mashimo H, Chang KJ, Muthusamy VR, Edmundowicz SA, Spechler SJ, Siddiqui AA, Souza RF, Infantolino A, Falk GW, Kimmey MB, Madanick RD, Chak A, Lightdale CJ. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med. 2009;360:2277-2288. [PMID: 19474425 DOI: 10.1056/nejmoa0808145] [Cited by in Crossref: 951] [Cited by in F6Publishing: 342] [Article Influence: 73.2] [Reference Citation Analysis]
Number Citing Articles
1 Ganz RA. The future of endoscopic esophageal therapy--what comes next. Gastrointest Endosc Clin N Am 2010;20:147-59, viii. [PMID: 19951800 DOI: 10.1016/j.giec.2009.07.010] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Villiger M, Soroka A, Tearney GJ, Bouma BE, Vakoc BJ. Injury depth control from combined wavelength and power tuning in scanned beam laser thermal therapy. J Biomed Opt 2011;16:118001. [PMID: 22112139 DOI: 10.1117/1.3647581] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
3 Gregson EM, Fitzgerald RC. Biomarkers for dysplastic Barrett's: ready for prime time? World J Surg 2015;39:568-77. [PMID: 24844657 DOI: 10.1007/s00268-014-2640-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
4 del Genio G, del Genio F, Schettino P, Limongelli P, Tolone S, Brusciano L, Avellino M, Vitiello C, Docimo G, Pezzullo A, Docimo L. Esophageal papilloma: Flexible endoscopic ablation by radiofrequency. World J Gastrointest Endosc 2015; 7(3): 290-294 [PMID: 25789102 DOI: 10.4253/wjge.v7.i3.290] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
5 Wartolowska K, Collins GS, Hopewell S, Judge A, Dean BJ, Rombach I, Beard DJ, Carr AJ. Feasibility of surgical randomised controlled trials with a placebo arm: a systematic review. BMJ Open 2016;6:e010194. [PMID: 27008687 DOI: 10.1136/bmjopen-2015-010194] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
6 Lipman G, Haidry RJ. Endoscopic management of Barrett's and early oesophageal neoplasia. Frontline Gastroenterol 2017;8:138-42. [PMID: 28839898 DOI: 10.1136/flgastro-2016-100763] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
7 O’Connell K, Velanovich V. Effects of Nissen fundoplication on endoscopic endoluminal radiofrequency ablation of Barrett’s esophagus. Surg Endosc. 2011;25:830-834. [PMID: 20676687 DOI: 10.1007/s00464-010-1270-0] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
8 Garman KS, Kruger L, Thomas S, Swiderska-Syn M, Moser BK, Diehl AM, McCall SJ. Ductal metaplasia in oesophageal submucosal glands is associated with inflammation and oesophageal adenocarcinoma. Histopathology 2015;67:771-82. [PMID: 25847432 DOI: 10.1111/his.12707] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
9 Kaul V, Bittner K, Ullah A, Kothari S. Liquid nitrogen spray cryotherapy-based multimodal endoscopic management of dysplastic Barrett's esophagus and early esophageal neoplasia: retrospective review and long-term follow-up at an academic tertiary care referral center. Dis Esophagus 2020;33:doz095. [PMID: 31909783 DOI: 10.1093/dote/doz095] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Pecere S, Costamagna G. Endoscopic therapy for confirmed low-grade dysplasia in Barrett's esophagus. Transl Gastroenterol Hepatol 2018;3:83. [PMID: 30505970 DOI: 10.21037/tgh.2018.10.01] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Ashrafi D, Memon B, Memon MA. Management of oesophageal intramucosal carcinoma. BMJ Case Rep 2018;2018:bcr-2018-224893. [PMID: 30217797 DOI: 10.1136/bcr-2018-224893] [Reference Citation Analysis]
12 Shah PM, Gerdes H. Endoscopic options for early stage esophageal cancer. J Gastrointest Oncol. 2015;6:20-30. [PMID: 25642334 DOI: 10.3978/j.issn.2078-6891.2014.096] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
13 Theron BT, Padmanabhan H, Aladin H, Smith P, Campbell E, Nightingale P, Cooper BT, Trudgill NJ. The risk of oesophageal adenocarcinoma in a prospectively recruited Barrett's oesophagus cohort. United European Gastroenterol J 2016;4:754-61. [PMID: 28408992 DOI: 10.1177/2050640616632419] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
14 Wang KK. The essence of management of Barrett's esophagus. Gastrointest Endosc 2013;78:702-3. [PMID: 24120334 DOI: 10.1016/j.gie.2013.07.006] [Reference Citation Analysis]
15 Schoppmann SF, Azari R, Riegler FM. Selected commentary to "Incidence of adenocarcinoma among patients with Barrett's esophagus". Eur Surg 2012;44:291-5. [DOI: 10.1007/s10353-012-0101-z] [Reference Citation Analysis]
16 Falk GL, Vivian SJ. Laryngopharyngeal reflux: diagnosis, treatment and latest research. Eur Surg 2016;48:74-91. [DOI: 10.1007/s10353-016-0385-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
17 Wang KK, Tian JM, Gorospe E, Penfield J, Prasad G, Goddard T, Wongkeesong M, Buttar NS, Lutzke L, Krishnadath S. Medical and endoscopic management of high-grade dysplasia in Barrett's esophagus. Dis Esophagus 2012;25:349-55. [PMID: 22409514 DOI: 10.1111/j.1442-2050.2012.01342.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
18 Heller SJ, Tokar JL. Current status of advanced gastrointestinal endoscopy training fellowships in the United States. Adv Med Educ Pract. 2011;2:25-34. [PMID: 23745073 DOI: 10.2147/amep.s13310] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
19 Castela J, Serrano M, Ferro SM, Pereira DV, Chaves P, Pereira AD. Buried Barrett's Esophagus with High-Grade Dysplasia after Radiofrequency Ablation.Clin Endosc. 2019;52:269-272. [PMID: 30300980 DOI: 10.5946/ce.2018.124] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
20 Choi KKH, Sanagapalli S. Barrett’s esophagus: Review of natural history and comparative efficacy of endoscopic and surgical therapies. World J Gastrointest Oncol 2022; 14(3): 568-586 [PMID: 35321279 DOI: 10.4251/wjgo.v14.i3.568] [Reference Citation Analysis]
21 Wani S, Drahos J, Cook MB, Rastogi A, Bansal A, Yen R, Sharma P, Das A. Comparison of endoscopic therapies and surgical resection in patients with early esophageal cancer: a population-based study. Gastrointest Endosc. 2014;79:224-232.e1. [PMID: 24060519 DOI: 10.1016/j.gie.2013.08.002] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 7.6] [Reference Citation Analysis]
22 Rees JR, Lao-Sirieix P, Wong A, Fitzgerald RC: Treatment for Barrett’s oesophagus Cochrane Database Syst Rev. 2010;CD004060. [PMID: 20091557 DOI: 10.1002/14651858.cd004060.pub2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
23 Hur C, Choi SE, Rubenstein JH, Kong CY, Nishioka NS, Provenzale DT, Inadomi JM. The cost effectiveness of radiofrequency ablation for Barrett's esophagus. Gastroenterology. 2012;143:567-575. [PMID: 22626608 DOI: 10.1053/j.gastro.2012.05.010] [Cited by in Crossref: 112] [Cited by in F6Publishing: 93] [Article Influence: 11.2] [Reference Citation Analysis]
24 Shaheen NJ, Greenwald BD, Peery AF, Dumot JA, Nishioka NS, Wolfsen HC, Burdick JS, Abrams JA, Wang KK, Mallat D, Johnston MH, Zfass AM, Smith JO, Barthel JS, Lightdale CJ. Safety and efficacy of endoscopic spray cryotherapy for Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc 2010;71:680-5. [PMID: 20363409 DOI: 10.1016/j.gie.2010.01.018] [Cited by in Crossref: 174] [Cited by in F6Publishing: 138] [Article Influence: 14.5] [Reference Citation Analysis]
25 Aranda-Hernandez J, Cirocco M, Marcon N. Treatment of dysplasia in barrett esophagus. Clin Endosc 2014;47:55-64. [PMID: 24570884 DOI: 10.5946/ce.2014.47.1.55] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
26 Smith MS, Cash B, Konda V, Trindade AJ, Gordon S, DeMeester S, Joshi V, Diehl D, Ganguly E, Mashimo H, Singh S, Jobe B, McKinley M, Wallace M, Komatsu Y, Thakkar S, Schnoll-Sussman F, Sharaiha R, Kahaleh M, Tarnasky P, Wolfsen H, Hawes R, Lipham J, Khara H, Pleskow D, Navaneethan U, Kedia P, Hasan M, Sethi A, Samarasena J, Siddiqui UD, Gress F, Rodriguez R, Lee C, Gonda T, Waxman I, Hyder S, Poneros J, Sharzehi K, Di Palma JA, Sejpal DV, Oh D, Hagen J, Rothstein R, Sawhney M, Berzin T, Malik Z, Chang K. Volumetric laser endomicroscopy and its application to Barrett's esophagus: results from a 1,000 patient registry. Dis Esophagus 2019;32:doz029. [PMID: 31037293 DOI: 10.1093/dote/doz029] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
27 Dugalic P, Djuranovic S, Pavlovic-Markovic A, Dugalic V, Tomasevic R, Gluvic Z, Obradovic M, Bajic V, Isenovic ER. Proton Pump Inhibitors and Radiofrequency Ablation for Treatment of Barrett's Esophagus. Mini Rev Med Chem 2020;20:975-87. [PMID: 31644405 DOI: 10.2174/1389557519666191015203636] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Belghazi K, Bergman J, Pouw RE. Endoscopic Resection and Radiofrequency Ablation for Early Esophageal Neoplasia. Dig Dis. 2016;34:469-475. [PMID: 27333327 DOI: 10.1159/000445221] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
29 Reid BJ, Kostadinov R, Maley CC. New strategies in Barrett's esophagus: integrating clonal evolutionary theory with clinical management. Clin Cancer Res 2011;17:3512-9. [PMID: 21498395 DOI: 10.1158/1078-0432.CCR-09-2358] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
30 Ciccozzi M, Menga R, Ricci G, Vitali MA, Angeletti S, Sirignano A, Tambone V. Critical review of sham surgery clinical trials: Confounding factors analysis. Ann Med Surg (Lond) 2016;12:21-6. [PMID: 27872745 DOI: 10.1016/j.amsu.2016.10.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
31 Pech O. Esophagus: How should early neoplasia in Barrett esophagus be treated? Nat Rev Gastroenterol Hepatol 2010;7:193-4. [PMID: 20376094 DOI: 10.1038/nrgastro.2010.34] [Reference Citation Analysis]
32 Qiu L, Chuttani R, Pleskow DK, Turzhitsky V, Khan U, Zakharov YN, Zhang L, Berzin TM, Yee EU, Sawhney MS, Li Y, Vitkin E, Goldsmith JD, Itzkan I, Perelman LT. Multispectral light scattering endoscopic imaging of esophageal precancer. Light Sci Appl 2018;7:17174. [PMID: 30839534 DOI: 10.1038/lsa.2017.174] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
33 Feo CV, Patti MG. Importance of a multidisciplinary approach for the treatment of Barrett's esophagus. Updates Surg 2011;63:5-9. [PMID: 21308492 DOI: 10.1007/s13304-011-0049-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
34 Singer ME, Smith MS. Wide Area Transepithelial Sampling with Computer-Assisted Analysis (WATS3D) Is Cost-Effective in Barrett's Esophagus Screening. Dig Dis Sci 2021;66:1572-9. [PMID: 32578042 DOI: 10.1007/s10620-020-06412-1] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
35 Kang TW, Rhim H, Lee MW, Kim YS, Choi D, Lim HK. Terminology and reporting criteria for radiofrequency ablation of tumors in the scientific literature: systematic review of compliance with reporting standards. Korean J Radiol 2014;15:95-107. [PMID: 24497798 DOI: 10.3348/kjr.2014.15.1.95] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
36 Visrodia K, Zakko L, Wang KK. Radiofrequency Ablation of Barrett's Esophagus: Efficacy, Complications, and Durability. Gastrointest Endosc Clin N Am 2017;27:491-501. [PMID: 28577770 DOI: 10.1016/j.giec.2017.03.003] [Cited by in Crossref: 5] [Article Influence: 1.0] [Reference Citation Analysis]
37 Bennett C, Vakil N, Bergman J, Harrison R, Odze R, Vieth M, Sanders S, Gay L, Pech O, Longcroft-Wheaton G, Romero Y, Inadomi J, Tack J, Corley DA, Manner H, Green S, Al Dulaimi D, Ali H, Allum B, Anderson M, Curtis H, Falk G, Fennerty MB, Fullarton G, Krishnadath K, Meltzer SJ, Armstrong D, Ganz R, Cengia G, Going JJ, Goldblum J, Gordon C, Grabsch H, Haigh C, Hongo M, Johnston D, Forbes-Young R, Kay E, Kaye P, Lerut T, Lovat LB, Lundell L, Mairs P, Shimoda T, Spechler S, Sontag S, Malfertheiner P, Murray I, Nanji M, Poller D, Ragunath K, Regula J, Cestari R, Shepherd N, Singh R, Stein HJ, Talley NJ, Galmiche JP, Tham TC, Watson P, Yerian L, Rugge M, Rice TW, Hart J, Gittens S, Hewin D, Hochberger J, Kahrilas P, Preston S, Sampliner R, Sharma P, Stuart R, Wang K, Waxman I, Abley C, Loft D, Penman I, Shaheen NJ, Chak A, Davies G, Dunn L, Falck-Ytter Y, Decaestecker J, Bhandari P, Ell C, Griffin SM, Attwood S, Barr H, Allen J, Ferguson MK, Moayyedi P, Jankowski JA. Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology. 2012;143:336-346. [PMID: 22537613 DOI: 10.1053/j.gastro.2012.04.032] [Cited by in Crossref: 263] [Cited by in F6Publishing: 225] [Article Influence: 26.3] [Reference Citation Analysis]
38 Forgacs I, Ashton R, Allum W, Bowley T, Brown H, Coleman MP, Fitzgerald R, Glynn M, Hiom S, Jones R, Machesney M, Maher J, Pereira SP, Steele R, Veitch A, Wyatt S. Conference report: improving outcomes for gastrointestinal cancer in the UK. Frontline Gastroenterol 2018;9:49-61. [PMID: 29484161 DOI: 10.1136/flgastro-2016-100713] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
39 Chen H, Hu Y, Fang Y, Djukic Z, Yamamoto M, Shaheen NJ, Orlando RC, Chen X. Nrf2 deficiency impairs the barrier function of mouse oesophageal epithelium. Gut 2014;63:711-9. [PMID: 23676441 DOI: 10.1136/gutjnl-2012-303731] [Cited by in F6Publishing: 38] [Reference Citation Analysis]
40 Wang KK. Endoscopic treatment for Barrett's esophagus and early esophageal cancer. J Gastrointest Surg 2010;14:946-7. [PMID: 20146023 DOI: 10.1007/s11605-009-1144-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
41 Belghazi K, Cipollone I, Bergman JJ, Pouw RE. Current Controversies in Radiofrequency Ablation Therapy for Barrett's Esophagus. Curr Treat Options Gastroenterol 2016;14:1-18. [PMID: 26891725 DOI: 10.1007/s11938-016-0080-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
42 Ngamruengphong S, Wolfsen HC, Wallace MB. Survival of patients with superficial esophageal adenocarcinoma after endoscopic treatment vs surgery. Clin Gastroenterol Hepatol. 2013;11:1424-1429.e2; quiz e81. [PMID: 23735443 DOI: 10.1016/j.cgh.2013.05.025] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 5.3] [Reference Citation Analysis]
43 Montgomery E, Voltaggio L, Canto MI. Much ado about very little (lamina propria)? Gastrointest Endosc. 2012;75:19-22. [PMID: 22196808 DOI: 10.1016/j.gie.2011.07.041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
44 Cholapranee A, Trindade AJ. Challenges in Endoscopic Therapy of Dysplastic Barrett's Esophagus. Curr Treat Options Gastroenterol 2019;17:32-47. [PMID: 30663018 DOI: 10.1007/s11938-019-00215-8] [Reference Citation Analysis]
45 Chadwick G, Faulkner J, Ley-Greaves R, Vlavianos P, Goldin R, Hoare J. Treatment of dysplastic Barrett’s Oesophagus in lower volume centres after structured training. World J Gastrointest Endosc 2015; 7(1): 66-72 [PMID: 25610536 DOI: 10.4253/wjge.v7.i1.66] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
46 He S, Bergman J, Zhang Y, Weusten B, Xue L, Qin X, Dou L, Liu Y, Fleischer D, Lu N, Dawsey SM, Wang GQ. Endoscopic radiofrequency ablation for early esophageal squamous cell neoplasia: report of safety and effectiveness from a large prospective trial. Endoscopy. 2015;47:398-408. [PMID: 25668428 DOI: 10.1055/s-0034-1391285] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
47 Shimamura Y, Ikeya T, Marcon N, Mosko JD. Endoscopic diagnosis and treatment of early esophageal squamous neoplasia. World J Gastrointest Endosc 2017; 9(9): 438-447 [PMID: 28979708 DOI: 10.4253/wjge.v9.i9.438] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
48 Lisovsky M, Srivastava A. Barrett Esophagus: Evolving Concepts in Diagnosis and Neoplastic Progression. Surg Pathol Clin 2013;6:475-96. [PMID: 26839097 DOI: 10.1016/j.path.2013.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
49 Yachimski P, Hur C. Evidence-based endoscopic management of Barrett's esophagus. Gastroenterol Rep (Oxf) 2015;3:54-62. [PMID: 25237038 DOI: 10.1093/gastro/gou059] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
50 Okoro NI, Tomizawa Y, Dunagan KT, Lutzke LS, Wang KK, Prasad GA. Safety of prior endoscopic mucosal resection in patients receiving radiofrequency ablation of Barrett's esophagus. Clin Gastroenterol Hepatol. 2012;10:150-154. [PMID: 22056303 DOI: 10.1016/j.cgh.2011.10.030] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 3.9] [Reference Citation Analysis]
51 Wang WL, Chang IW, Chen CC, Chang WL, Chu YY, Wu PH, Tai WC, Chen PY, Hsieh PH, Chung CS, Chang CY, Lin JT, Wang HP, Lee CT. Predictors for postoperative esophageal stricture after balloon-based radiofrequency ablation for early esophageal squamous neoplasia: a multicenter validation study. Therap Adv Gastroenterol 2016;9:257-64. [PMID: 27134656 DOI: 10.1177/1756283X16633051] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
52 Amlashi FG, Wang X, Davila RE, Maru DM, Bhutani MS, Lee JH, Weston BR, Mizrak Kaya D, Vassilakopoulou M, Harada K, Blum Murphy MA, Rice DC, Hofstetter WL, Davila M, Nguyen QN, Ajani JA. Barrett's Esophagus after Bimodality Therapy in Patients with Esophageal Adenocarcinoma. Oncology 2018;95:81-90. [PMID: 29843157 DOI: 10.1159/000488489] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
53 Ertan A, Zaheer I, Correa AM, Thosani N, Blackmon SH. Photodynamic therapy vs radiofrequency ablation for Barrett’s dysplasia: Efficacy, safety and cost-comparison. World J Gastroenterol 2013; 19(41): 7106-7113 [PMID: 24222954 DOI: 10.3748/wjg.v19.i41.7106] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
54 Reid BJ. Genomics, Endoscopy, and Control of Gastroesophageal Cancers: A Perspective. Cell Mol Gastroenterol Hepatol 2017;3:359-66. [PMID: 28462378 DOI: 10.1016/j.jcmgh.2017.02.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
55 Wartolowska K, Judge A, Hopewell S, Collins GS, Dean BJ, Rombach I, Brindley D, Savulescu J, Beard DJ, Carr AJ. Use of placebo controls in the evaluation of surgery: systematic review. BMJ 2014;348:g3253. [PMID: 24850821 DOI: 10.1136/bmj.g3253] [Cited by in Crossref: 139] [Cited by in F6Publishing: 126] [Article Influence: 17.4] [Reference Citation Analysis]
56 Bedi AO, Kwon RS, Rubenstein JH, Piraka CR, Elta GH, Scheiman JM, Elmunzer BJ. A survey of expert follow-up practices after successful endoscopic eradication therapy for Barrett’s esophagus with high-grade dysplasia and intramucosal adenocarcinoma. Gastrointest Endosc. 2013;78:696-701. [PMID: 23711553 DOI: 10.1016/j.gie.2013.04.196] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
57 Leggett CL, Gorospe EC, Wang KK. Endoscopic therapy for Barrett's esophagus and early esophageal adenocarcinoma. Gastroenterol Clin North Am 2013;42:175-85. [PMID: 23452637 DOI: 10.1016/j.gtc.2012.11.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
58 Orman ES, Kim HP, Bulsiewicz WJ, Cotton CC, Dellon ES, Spacek MB, Chen X, Madanick RD, Pasricha S, Shaheen NJ. Intestinal metaplasia recurs infrequently in patients successfully treated for Barrett’s esophagus with radiofrequency ablation. Am J Gastroenterol. 2013;108:187-195; quiz 196. [PMID: 23247578 DOI: 10.1038/ajg.2012.413] [Cited by in Crossref: 70] [Cited by in F6Publishing: 50] [Article Influence: 7.0] [Reference Citation Analysis]
59 Rayner-Hartley E, Takach O, Galorport C, Enns RA. Diagnosis and Management of Barrett's Esophagus: A Retrospective Study Comparing the Endoscopic Assessment of Early Esophageal Lesions in the Community versus a Specialized Center. Can J Gastroenterol Hepatol 2016;2016:5749573. [PMID: 27446850 DOI: 10.1155/2016/5749573] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
60 Perry KA, Walker JP, Salazar M, Suzo A, Hazey JW, Melvin WS. Endoscopic management of high-grade dysplasia and intramucosal carcinoma: experience in a large academic medical center. Surg Endosc. 2014;28:777-782. [PMID: 24122245 DOI: 10.1007/s00464-013-3240-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
61 Raphael KL, Stewart M, Sejpal DV, Cheung M, Whitson MJ, Han D, Benias PC, Lee C, Miller LS, Trindade AJ. Adjunctive Yield of Wide-Area Transepithelial Sampling for Dysplasia Detection After Advanced Imaging and Random Biopsies in Barrett's Esophagus. Clin Transl Gastroenterol 2019;10:e00107. [PMID: 31833863 DOI: 10.14309/ctg.0000000000000107] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
62 Johnson EA, De Lee R, Agni R, Pfau P, Reichelderfer M, Gopal DV. Probe-Based Confocal Laser Endomicroscopy to Guide Real-Time Endoscopic Therapy in Barrett's Esophagus with Dysplasia. Case Rep Gastroenterol. 2012;6:285-292. [PMID: 22754488 DOI: 10.1159/000338835] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
63 Shaheen NJ, Falk GW, Iyer PG, Gerson LB; American College of Gastroenterology. ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus. Am J Gastroenterol. 2016;111:30-50; quiz 51. [PMID: 26526079 DOI: 10.1038/ajg.2015.322] [Cited by in Crossref: 793] [Cited by in F6Publishing: 630] [Article Influence: 113.3] [Reference Citation Analysis]
64 Luigiano C, Iabichino G, Eusebi LH, Arena M, Consolo P, Morace C, Opocher E, Mangiavillano B. Outcomes of Radiofrequency Ablation for Dysplastic Barrett's Esophagus: A Comprehensive Review. Gastroenterol Res Pract. 2016;2016:4249510. [PMID: 28070182 DOI: 10.1155/2016/4249510] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
65 Cotton CC, Wolf WA, Pasricha S, Li N, Madanick RD, Spacek MB, Ferrell K, Dellon ES, Shaheen NJ. Recurrent intestinal metaplasia after radiofrequency ablation for Barrett's esophagus: endoscopic findings and anatomic location. Gastrointest Endosc 2015;81:1362-9. [PMID: 25817897 DOI: 10.1016/j.gie.2014.12.029] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 5.6] [Reference Citation Analysis]
66 Spechler SJ, Fitzgerald RC, Prasad GA, Wang KK. History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus. Gastroenterology. 2010;138:854-869. [PMID: 20080098 DOI: 10.1053/j.gastro.2010.01.002] [Cited by in Crossref: 142] [Cited by in F6Publishing: 112] [Article Influence: 11.8] [Reference Citation Analysis]
67 Reid BJ, Li X, Galipeau PC, Vaughan TL. Barrett’s oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat Rev Cancer. 2010;10:87-101. [PMID: 20094044 DOI: 10.1038/nrc2773] [Cited by in Crossref: 282] [Cited by in F6Publishing: 254] [Article Influence: 23.5] [Reference Citation Analysis]
68 Reed MAC, Singhal R, Ludwig C, Carrigan JB, Ward DG, Taniere P, Alderson D, Günther UL. Metabolomic Evidence for a Field Effect in Histologically Normal and Metaplastic Tissues in Patients with Esophageal Adenocarcinoma. Neoplasia 2017;19:165-74. [PMID: 28152423 DOI: 10.1016/j.neo.2016.11.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
69 Zaninotto G, Bennett C. Surveillance for low-grade dysplastic Barrett's oesophagus: one size fits all? World J Surg 2015;39:578-85. [PMID: 24919861 DOI: 10.1007/s00268-014-2661-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
70 Guthikonda A, Cotton CC, Madanick RD, Spacek MB, Moist SE, Ferrell K, Dellon ES, Shaheen NJ. Clinical Outcomes Following Recurrence of Intestinal Metaplasia After Successful Treatment of Barrett's Esophagus With Radiofrequency Ablation. Am J Gastroenterol 2017;112:87-94. [PMID: 27725648 DOI: 10.1038/ajg.2016.451] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 6.7] [Reference Citation Analysis]
71 Londono R, Badylak SF. Regenerative Medicine Strategies for Esophageal Repair. Tissue Eng Part B Rev 2015;21:393-410. [PMID: 25813694 DOI: 10.1089/ten.TEB.2015.0014] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
72 Mehravar S, Banerjee B, Chatrath H, Amirsolaimani B, Patel K, Patel C, Norwood RA, Peyghambarian N, Kieu K. Label-free multi-photon imaging of dysplasia in Barrett's esophagus. Biomed Opt Express 2016;7:148-57. [PMID: 26819824 DOI: 10.1364/BOE.7.000148] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
73 Brown J, Alsop B, Gupta N, Buckles DC, Olyaee MS, Vennalaganti P, Kanakadandi VN, Saligram S, Sharma P. Effectiveness of focal vs. balloon radiofrequency ablation devices in the treatment of Barrett's esophagus. United European Gastroenterol J 2016;4:236-41. [PMID: 27087952 DOI: 10.1177/2050640615594549] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
74 Sami SS, Haboubi HN, Ang Y, Boger P, Bhandari P, de Caestecker J, Griffiths H, Haidry R, Laasch HU, Patel P, Paterson S, Ragunath K, Watson P, Siersema PD, Attwood SE. UK guidelines on oesophageal dilatation in clinical practice. Gut. 2018;67:1000-1023. [PMID: 29478034 DOI: 10.1136/gutjnl-2017-315414] [Cited by in Crossref: 45] [Cited by in F6Publishing: 29] [Article Influence: 11.3] [Reference Citation Analysis]
75 Kestens C, Siersema PD. Endoscopic treatment for dysplastic Barrett's esophagus. World J Surg 2015;39:606-7. [PMID: 25189451 DOI: 10.1007/s00268-014-2764-z] [Reference Citation Analysis]
76 Garud SS, Keilin S, Cai Q, Willingham FF. Diagnosis and management of Barrett's esophagus for the endoscopist. Therap Adv Gastroenterol 2010;3:227-38. [PMID: 21180605 DOI: 10.1177/1756283X10365439] [Cited by in Crossref: 22] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
77 Cotton CC, Haidry R, Thrift AP, Lovat L, Shaheen NJ. Development of Evidence-Based Surveillance Intervals After Radiofrequency Ablation of Barrett's Esophagus. Gastroenterology 2018;155:316-326.e6. [PMID: 29655833 DOI: 10.1053/j.gastro.2018.04.011] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
78 Jagadesham VP, Kelty CJ. Low grade dysplasia in Barrett’s esophagus: Should we worry? World J Gastrointest Pathophysiol 2014; 5(2): 91-99 [PMID: 24891980 DOI: 10.4291/wjgp.v5.i2.91] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
79 Bird-lieberman EL, Neves AA, Lao-sirieix P, O'donovan M, Novelli M, Lovat LB, Eng WS, Mahal LK, Brindle KM, Fitzgerald RC. Molecular imaging using fluorescent lectins permits rapid endoscopic identification of dysplasia in Barrett's esophagus. Nat Med 2012;18:315-21. [DOI: 10.1038/nm.2616] [Cited by in Crossref: 178] [Cited by in F6Publishing: 154] [Article Influence: 17.8] [Reference Citation Analysis]
80 Alvi MA, Liu X, O’Donovan M, Newton R, Wernisch L, Shannon NB, Shariff K, di Pietro M, Bergman JJ, Ragunath K. DNA methylation as an adjunct to histopathology to detect prevalent, inconspicuous dysplasia and early-stage neoplasia in Barrett’s esophagus. Clin Cancer Res. 2013;19:878-888. [PMID: 23243219 DOI: 10.1158/1078-0432.ccr-12-2880] [Cited by in Crossref: 54] [Cited by in F6Publishing: 22] [Article Influence: 5.4] [Reference Citation Analysis]
81 Chandra S, Gorospe EC, Leggett CL, Wang KK. Barrett's esophagus in 2012: updates in pathogenesis, treatment, and surveillance. Curr Gastroenterol Rep 2013;15:322. [PMID: 23605564 DOI: 10.1007/s11894-013-0322-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
82 Katzka DA, Fitzgerald RC. Time to Challenge Current Strategies for Detection of Barrett's Esophagus and Esophageal Adenocarcinoma. Dig Dis Sci 2020;65:18-21. [PMID: 31754994 DOI: 10.1007/s10620-019-05965-0] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
83 Wartolowska K, Beard D, Carr A. Blinding in trials of interventional procedures is possible and worthwhile. F1000Res 2017;6:1663. [PMID: 29259763 DOI: 10.12688/f1000research.12528.2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
84 Kim HP, Bulsiewicz WJ, Cotton CC, Dellon ES, Spacek MB, Chen X, Madanick RD, Pasricha S, Shaheen NJ. Focal endoscopic mucosal resection before radiofrequency ablation is equally effective and safe compared with radiofrequency ablation alone for the eradication of Barrett's esophagus with advanced neoplasia. Gastrointest Endosc. 2012;76:733-739. [PMID: 22732872 DOI: 10.1016/j.gie.2012.04.459] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 5.4] [Reference Citation Analysis]
85 McDevitt D, Mason A. Treating Barrett esophagus with radiofrequency ablation. Nursing 2018;48:26-32. [PMID: 29280837 DOI: 10.1097/01.NURSE.0000527594.94344.6f] [Reference Citation Analysis]
86 Sullivan R, Mulki R, Peter S. The role of ablation in the treatment of dysplastic Barrett's esophagus. Ther Adv Gastrointest Endosc 2021;14:26317745211049967. [PMID: 34708203 DOI: 10.1177/26317745211049967] [Reference Citation Analysis]
87 Eluri S, Paterson A, Lauren BN, O'Donovan M, Bhandari P, di Pietro M, Lee M, Haidry R, Lovat L, Ragunath K, Hur C, Fitzgerald RC, Shaheen NJ. Utility and Cost-Effectiveness of a Nonendoscopic Approach to Barrett's Esophagus Surveillance After Endoscopic Therapy. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00147-6. [PMID: 33581357 DOI: 10.1016/j.cgh.2021.02.013] [Reference Citation Analysis]
88 Fleischer DE, Odze R, Overholt BF, Carroll J, Chang KJ, Das A, Goldblum J, Miller D, Lightdale CJ, Peters J. The case for endoscopic treatment of non-dysplastic and low-grade dysplastic Barrett's esophagus. Dig Dis Sci. 2010;55:1918-1931. [PMID: 20405211 DOI: 10.1007/s10620-010-1218-1] [Cited by in Crossref: 51] [Cited by in F6Publishing: 32] [Article Influence: 4.3] [Reference Citation Analysis]
89 Spechler SJ. Barrett’s Esophagus without dysplasia: wait or ablate? Dig Dis Sci. 2011;56:1926-1928. [PMID: 21509560 DOI: 10.1007/s10620-011-1706-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
90 Titi M, Overhiser A, Ulusarac O, Falk GW, Chak A, Wang K, Sharma P. Development of subsquamous high-grade dysplasia and adenocarcinoma after successful radiofrequency ablation of Barrett's esophagus. Gastroenterology 2012;143:564-566.e1. [PMID: 22561053 DOI: 10.1053/j.gastro.2012.04.051] [Cited by in Crossref: 95] [Cited by in F6Publishing: 76] [Article Influence: 9.5] [Reference Citation Analysis]
91 Yamamoto Y, Wang X, Bertrand D, Kern F, Zhang T, Duleba M, Srivastava S, Khor CC, Hu Y, Wilson LH, Blaszyk H, Rolshud D, Teh M, Liu J, Howitt BE, Vincent M, Crum CP, Nagarajan N, Ho KY, McKeon F, Xian W. Mutational spectrum of Barrett's stem cells suggests paths to initiation of a precancerous lesion. Nat Commun 2016;7:10380. [PMID: 26783136 DOI: 10.1038/ncomms10380] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 6.8] [Reference Citation Analysis]
92 Bowman CJ, Zhang R, Balitzer D, Wang D, Rabinovitch PS, Kővári BP, Mattis AN, Kakar S, Lauwers GY, Choi WT. Persistent or recurrent Barrett's neoplasia after an endoscopic therapy session is associated with DNA content abnormality and can be detected by DNA flow cytometric analysis of paraffin-embedded tissue. Mod Pathol 2021. [PMID: 34108638 DOI: 10.1038/s41379-021-00832-8] [Reference Citation Analysis]
93 Hamade N, Sharma P. Ablation Therapy for Barrett's Esophagus: New Rules for Changing Times. Curr Gastroenterol Rep 2017;19:48. [PMID: 28819902 DOI: 10.1007/s11894-017-0589-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
94 Giroux V, Rustgi AK. Metaplasia: tissue injury adaptation and a precursor to the dysplasia-cancer sequence. Nat Rev Cancer. 2017;17:594-604. [PMID: 28860646 DOI: 10.1038/nrc.2017.68] [Cited by in Crossref: 91] [Cited by in F6Publishing: 82] [Article Influence: 18.2] [Reference Citation Analysis]
95 Choi SE, Hur C. Screening and surveillance for Barrett's esophagus: current issues and future directions. Curr Opin Gastroenterol 2012;28:377-81. [PMID: 22508325 DOI: 10.1097/MOG.0b013e328353d58e] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
96 Patti MG, Waxman I. Gastroesophageal reflux disease: From heartburn to cancer. World J Gastroenterol 2010; 16(30): 3743-3744 [PMID: 20698034 DOI: 10.3748/wjg.v16.i30.3743] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
97 Dunn JM, Hveem T, Pretorius M, Oukrif D, Nielsen B, Albregtsen F, Lovat LB, Novelli MR, Danielsen HE. Comparison of nuclear texture analysis and image cytometric DNA analysis for the assessment of dysplasia in Barrett's oesophagus. Br J Cancer. 2011;105:1218-1223. [PMID: 21934680 DOI: 10.1038/bjc.2011.353] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
98 Macías-García F, Domínguez-Muñoz JE. Update on management of Barrett's esophagus. World J Gastrointest Pharmacol Ther 2016; 7(2): 227-234 [PMID: 27158538 DOI: 10.4292/wjgpt.v7.i2.227] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
99 Fernández-Esparrach G, Rodríguez-D'Jesús A. [Radiofrequency in the treatment of Barrett's esophagus]. Gastroenterol Hepatol 2011;34:35-40. [PMID: 21216043 DOI: 10.1016/j.gastrohep.2010.10.007] [Reference Citation Analysis]
100 Qiu L, Zhang L, Turzhitsky V, Khan U, Zakharov Y, Kantekure K, Vitkin E, Itzkan I, Pleskow DK, Sawhney M, Berzin TM, Goldsmith JD, Perelman LT. Multispectral Endoscopy with Light Gating for Early Cancer Detection. IEEE J Sel Top Quantum Electron 2019;25:7201309. [PMID: 31244520 DOI: 10.1109/JSTQE.2018.2854608] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 Konda VJ, Ferguson MK. Esophageal resection for high-grade dysplasia and intramucosal carcinoma: When and how? World J Gastroenterol 2010; 16(30): 3786-3792 [PMID: 20698041 DOI: 10.3748/wjg.v16.i30.3786] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
102 Lara LF, Silva R, Thakkar S, Stanich PP, Mai D, Samarasena JB. Multicenter case series of patients with small-bowel angiodysplasias treated with a small-bowel radiofrequency ablation catheter. VideoGIE 2020;5:162-7. [PMID: 32258850 DOI: 10.1016/j.vgie.2019.11.014] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
103 Falk GW. Barrett's oesophagus: frequency and prediction of dysplasia and cancer. Best Pract Res Clin Gastroenterol 2015;29:125-38. [PMID: 25743461 DOI: 10.1016/j.bpg.2015.01.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
104 Calvet X. Enfermedades esofágicas: enfermedad por reflujo gastroesofágico, esófago de Barrett y esofagitis eosinofílica. Gastroenterología y Hepatología 2011;34:27-35. [DOI: 10.1016/s0210-5705(11)70018-8] [Reference Citation Analysis]
105 Gregson EM, Bornschein J, Fitzgerald RC. Genetic progression of Barrett's oesophagus to oesophageal adenocarcinoma. Br J Cancer 2016;115:403-10. [PMID: 27441494 DOI: 10.1038/bjc.2016.219] [Cited by in F6Publishing: 32] [Reference Citation Analysis]
106 Cummings D, Wong J, Palm R, Hoffe S, Almhanna K, Vignesh S. Epidemiology, Diagnosis, Staging and Multimodal Therapy of Esophageal and Gastric Tumors. Cancers (Basel) 2021;13:582. [PMID: 33540736 DOI: 10.3390/cancers13030582] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
107 Lovat L. The new treatment paradigm for Barrett's dysplasia. Frontline Gastroenterol 2016;7:30-1. [PMID: 28839831 DOI: 10.1136/flgastro-2015-100584] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
108 Bronner MP. Barrett's Esophagus. Korean J Helicobacter Up Gastrointest Res 2014;14:131. [DOI: 10.7704/kjhugr.2014.14.3.131] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
109 Codipilly DC, Iyer PG. What's next for wide-area transepithelial sampling in Barrett's esophagus management? Gastrointest Endosc 2021:S0016-5107(21)01832-0. [PMID: 34916062 DOI: 10.1016/j.gie.2021.11.013] [Reference Citation Analysis]
110 Lagergren J. Oesophageal cancer in 2014: Advances in curatively intended treatment. Nat Rev Gastroenterol Hepatol 2015;12:74-5. [PMID: 25446726 DOI: 10.1038/nrgastro.2014.213] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
111 Uno K, Koike T, Shimosegawa T. Recent development of optical coherence tomography for preoperative diagnosis of esophageal malignancies. World J Gastrointest Endosc 2015; 7(9): 872-880 [PMID: 26240688 DOI: 10.4253/wjge.v7.i9.872] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
112 Alvarez H, Opalinska J, Zhou L, Sohal D, Fazzari MJ, Yu Y, Montagna C, Montgomery EA, Canto M, Dunbar KB. Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesis. PLoS Genet. 2011;7:e1001356. [PMID: 21483804 DOI: 10.1371/journal.pgen.1001356] [Cited by in Crossref: 75] [Cited by in F6Publishing: 73] [Article Influence: 6.8] [Reference Citation Analysis]
113 Jovov B, Shaheen NJ, Orlando GS, Djukic Z, Orlando RC. Defective barrier function in neosquamous epithelium. The American journal of gastroenterology. 2013;108:386-391. [PMID: 23318477 DOI: 10.1038/ajg.2012.440] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
114 Mannath J, Ragunath K. Role of endoscopy in early oesophageal cancer. Nat Rev Gastroenterol Hepatol. 2016;13:720-730. [PMID: 27807370 DOI: 10.1038/nrgastro.2016.148] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
115 Bird-lieberman E, Ford H, Fitzgerald R. Barrett’s oesophagus and oesophageal adenocarcinoma. Medicine 2011;39:142-8. [DOI: 10.1016/j.mpmed.2010.12.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
116 Genere JR, Visrodia K, Zakko L, Hoefnagel SJM, Wang KK. Spray cryotherapy versus continued radiofrequency ablation in persistent Barrett’s esophagus. Diseases of the Esophagus 2022. [DOI: 10.1093/dote/doab084] [Reference Citation Analysis]
117 Riegler M, Schoppmann SF. Selected commentary to “Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia. A randomized clinical trial”. Eur Surg 2014;46:133-6. [DOI: 10.1007/s10353-014-0262-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
118 Kristo I, Schoppmann S. Diagnosis and treatment of benign inflammatory esophageal diseases. Eur Surg 2015;47:188-98. [DOI: 10.1007/s10353-015-0329-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
119 Kroep S, Heberle CR, Curtius K, Kong CY, Lansdorp-Vogelaar I, Ali A, Wolf WA, Shaheen NJ, Spechler SJ, Rubenstein JH, Nishioka NS, Meltzer SJ, Hazelton WD, van Ballegooijen M, Tramontano AC, Gazelle GS, Luebeck EG, Inadomi JM, Hur C. Radiofrequency Ablation of Barrett's Esophagus Reduces Esophageal Adenocarcinoma Incidence and Mortality in a Comparative Modeling Analysis. Clin Gastroenterol Hepatol. 2017;15:1471-1474. [PMID: 28089850 DOI: 10.1016/j.cgh.2016.12.034] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
120 Schlottmann F, Patti MG. Current Concepts in Treatment of Barrett's Esophagus With and Without Dysplasia. J Gastrointest Surg 2017;21:1354-60. [PMID: 28353175 DOI: 10.1007/s11605-017-3371-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
121 Manner H, May A, Kouti I, Pech O, Vieth M, Ell C. Efficacy and safety of Hybrid-APC for the ablation of Barrett's esophagus. Surg Endosc. 2016;30:1364-1370. [PMID: 26104794 DOI: 10.1007/s00464-015-4336-1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 5.7] [Reference Citation Analysis]
122 Otaki F, Iyer PG. Point-Counterpoint: Screening and Surveillance for Barrett's Esophagus, Is It Worthwhile? Dig Dis Sci 2018;63:2081-93. [PMID: 29713986 DOI: 10.1007/s10620-018-5065-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
123 Zhou C, Tsai TH, Lee HC, Kirtane T, Figueiredo M, Tao YK, Ahsen OO, Adler DC, Schmitt JM, Huang Q. Characterization of buried glands before and after radiofrequency ablation by using 3-dimensional optical coherence tomography (with videos). Gastrointest Endosc. 2012;76:32-40. [PMID: 22482920 DOI: 10.1016/j.gie.2012.02.003] [Cited by in Crossref: 86] [Cited by in F6Publishing: 70] [Article Influence: 8.6] [Reference Citation Analysis]
124 Kurian AA, Swanström LL. Radiofrequency ablation in the management of Barrett's esophagus: present role and future perspective. Expert Rev Med Devices 2013;10:509-17. [PMID: 23895078 DOI: 10.1586/17434440.2013.811863] [Reference Citation Analysis]
125 Dam AN, Klapman J. A narrative review of Barrett's esophagus in 2020, molecular and clinical update.Ann Transl Med. 2020;8:1107. [PMID: 33145326 DOI: 10.21037/atm-20-4406] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
126 Bansal A, Kahrilas PJ. Treatment of GERD complications (Barrett's, peptic stricture) and extra-oesophageal syndromes. Best Pract Res Clin Gastroenterol 2010;24:961-8. [PMID: 21126707 DOI: 10.1016/j.bpg.2010.09.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
127 Sharaiha RZ, Freedberg DE, Abrams JA, Wang YC. Cost-effectiveness of chemoprevention with proton pump inhibitors in Barrett’s esophagus. Dig Dis Sci. 2014;59:1222-1230. [PMID: 24795040 DOI: 10.1007/s10620-014-3186-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
128 Barthet M. Endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine tumor. Ann Endocrinol (Paris) 2019;80:182-4. [PMID: 31053252 DOI: 10.1016/j.ando.2019.04.001] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
129 Roy HK, Backman V. Spectroscopic applications in gastrointestinal endoscopy. Clin Gastroenterol Hepatol 2012;10:1335-41. [PMID: 23059052 DOI: 10.1016/j.cgh.2012.10.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
130 Watari J, Oshima T, Fukui H, Tomita T, Miwa H. Carcinogenesis of Barrett's esophagus: a review of the clinical literature. Clin J Gastroenterol 2013;6:399-414. [PMID: 26182128 DOI: 10.1007/s12328-013-0412-z] [Reference Citation Analysis]
131 van Olphen SH, Ten Kate FJC, Doukas M, Kastelein F, Steyerberg EW, Stoop HA, Spaander MC, Looijenga LHJ, Bruno MJ, Biermann K; ProBar-Study Group. Value of cyclin A immunohistochemistry for cancer risk stratification in Barrett esophagus surveillance: A multicenter case-control study. Medicine (Baltimore) 2016;95:e5402. [PMID: 27893678 DOI: 10.1097/MD.0000000000005402] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
132 Spiceland CM, Elmunzer BJ, Paros S, Roof L, McVey M, Hawes R, Hoffman BJ, Elias PS. Salvage cryotherapy in patients undergoing endoscopic eradication therapy for complicated Barrett's esophagus. Endosc Int Open. 2019;7:E904-E911. [PMID: 31281876 DOI: 10.1055/a-0902-4587] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
133 Spechler SJ. Barrett’s esophagus: Clinical issues. Gastrointest Endosc Clin N Am. 2011;21:1-7. [PMID: 21112493 DOI: 10.1016/j.giec.2010.09.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
134 Orman ES, Li N, Shaheen NJ. Efficacy and durability of radiofrequency ablation for Barrett's Esophagus: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013;11:1245-1255. [PMID: 23644385 DOI: 10.1016/j.cgh.2013.03.039] [Cited by in Crossref: 180] [Cited by in F6Publishing: 135] [Article Influence: 20.0] [Reference Citation Analysis]
135 Stefanidis D, Hope WW, Kohn GP, Reardon PR, Richardson WS, Fanelli RD; SAGES Guidelines Committee. Guidelines for surgical treatment of gastroesophageal reflux disease. Surg Endosc. 2010;24:2647-2669. [PMID: 20725747 DOI: 10.1007/s00464-010-1267-8] [Cited by in Crossref: 267] [Cited by in F6Publishing: 157] [Article Influence: 22.3] [Reference Citation Analysis]
136 van Munster S, Nieuwenhuis E, Bisschops R, Willekens H, Weusten BLAM, Herrero LA, Bogte A, Alkhalaf A, Schenk BE, Schoon EJ, Curvers W, Koch AD, de Jonge PJF, Tang TJ, Nagengast WB, Westerhof J, Houben MHMG, Seewald S, Eijkemans MJC, Bergman JJGHM, Pouw RE. Dysplastic Recurrence After Successful Treatment for Early Barrett's Neoplasia: Development and Validation of a Prediction Model. Gastroenterology 2022:S0016-5085(22)00271-2. [PMID: 35306024 DOI: 10.1053/j.gastro.2022.03.020] [Reference Citation Analysis]
137 Ross-Innes CS, Debiram-Beecham I, O'Donovan M, Walker E, Varghese S, Lao-Sirieix P, Lovat L, Griffin M, Ragunath K, Haidry R, Sami SS, Kaye P, Novelli M, Disep B, Ostler R, Aigret B, North BV, Bhandari P, Haycock A, Morris D, Attwood S, Dhar A, Rees C, Rutter MD, Sasieni PD, Fitzgerald RC; BEST2 Study Group. Evaluation of a minimally invasive cell sampling device coupled with assessment of trefoil factor 3 expression for diagnosing Barrett's esophagus: a multi-center case-control study. PLoS Med 2015;12:e1001780. [PMID: 25634542 DOI: 10.1371/journal.pmed.1001780] [Cited by in Crossref: 144] [Cited by in F6Publishing: 136] [Article Influence: 20.6] [Reference Citation Analysis]
138 Chang K, Jackson CS, Vega KJ. Barrett's Esophagus: Diagnosis, Management, and Key Updates. Gastroenterol Clin North Am 2021;50:751-68. [PMID: 34717869 DOI: 10.1016/j.gtc.2021.08.009] [Reference Citation Analysis]
139 Qumseya B, Panossian AM, Rizk C, Cangemi D, Wolfsen C, Raimondo M, Woodward T, Wallace MB, Wolfsen H. Predictors of esophageal stricture formation post endoscopic mucosal resection. Clin Endosc 2014;47:155-61. [PMID: 24765598 DOI: 10.5946/ce.2014.47.2.155] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
140 Labenz J, Koop H, Tannapfel A, Kiesslich R, Hölscher AH. The epidemiology, diagnosis, and treatment of Barrett's carcinoma. Dtsch Arztebl Int 2015;112:224-33; quiz 234. [PMID: 25869347 DOI: 10.3238/arztebl.2015.0224] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
141 di Pietro M, Chan D, Fitzgerald RC, Wang KK. Screening for Barrett's Esophagus. Gastroenterology 2015;148:912-23. [PMID: 25701083 DOI: 10.1053/j.gastro.2015.02.012] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 5.1] [Reference Citation Analysis]
142 Rhee H, Wang DH. Cellular Origins of Barrett's Esophagus: the Search Continues. Curr Gastroenterol Rep 2018;20:51. [PMID: 30259225 DOI: 10.1007/s11894-018-0657-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
143 Knabe M, Blößer S, Wetzka J, Ell C, May A. Non-thermal ablation of non-neoplastic Barrett's esophagus with the novel EndoRotor® resection device. United European Gastroenterol J 2018;6:678-83. [PMID: 30083329 DOI: 10.1177/2050640618758214] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
144 Peery AF, Shaheen NJ. Esophagus: Endoscopic therapy for flat, dysplastic Barrett esophagus. Nat Rev Gastroenterol Hepatol 2011;8:186-7. [PMID: 21386808 DOI: 10.1038/nrgastro.2011.38] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
145 Polese L, Angriman I, Scarpa M, Pagano D, Parente P, Erroi F, Frego M, D'Amico DF, Norberto L. Diode laser treatment of Barrett's esophagus: long-term results. Lasers Med Sci. 2011;26:223-228. [PMID: 20821340 DOI: 10.1007/s10103-010-0836-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
146 Thota PN, Chak A. Is Mass Screening for Barrett's Esophagus a Myth or Reality? Clin Gastroenterol Hepatol 2019;17:610-2. [PMID: 30267863 DOI: 10.1016/j.cgh.2018.09.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
147 Cassani L, Slaughter JC, Yachimski P. Adherence to therapy for Barrett's esophagus-associated neoplasia. United European Gastroenterol J 2016;4:42-8. [PMID: 26966521 DOI: 10.1177/2050640615585469] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
148 Knabe M, May A, Ell C. Endoscopic Therapy of Early Carcinoma of the Oesophagus. Viszeralmedizin 2015;31:320-5. [PMID: 26989386 DOI: 10.1159/000441075] [Reference Citation Analysis]
149 Mkarimi M, Mashimo H. Advanced Imaging for Barrett's Esophagus and Early Neoplasia: Surface and Subsurface Imaging for Diagnosis and Management. Curr Gastroenterol Rep 2018;20:54. [PMID: 30302571 DOI: 10.1007/s11894-018-0661-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
150 . Scientific Surgery. British Journal of Surgery 2010;97:138-138. [DOI: 10.1002/bjs.6948] [Reference Citation Analysis]
151 Yachimski P, Maqbool S, Bhat YM, Richter JE, Falk GW, Vaezi MF. Control of acid and duodenogastroesophageal reflux (DGER) in patients with Barrett's esophagus. Am J Gastroenterol 2015;110:1143-8. [PMID: 26032153 DOI: 10.1038/ajg.2015.161] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
152 Tang Q, Wang J, Frank A, Lin J, Li Z, Chen CW, Jin L, Wu T, Greenwald BD, Mashimo H, Chen Y. Depth-resolved imaging of colon tumor using optical coherence tomography and fluorescence laminar optical tomography. Biomed Opt Express 2016;7:5218-32. [PMID: 28018738 DOI: 10.1364/BOE.7.005218] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
153 Raphael KL, Trindade AJ. Management of Barrett’s esophagus with dysplasia refractory to radiofrequency ablation. World J Gastroenterol 2020; 26(17): 2030-2039 [PMID: 32536772 DOI: 10.3748/wjg.v26.i17.2030] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
154 Codipilly DC, Iyer PG. Novel Screening Tests for Barrett's Esophagus. Curr Gastroenterol Rep 2019;21:42. [PMID: 31346777 DOI: 10.1007/s11894-019-0710-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
155 Bergman JJ, Zhang YM, He S, Weusten B, Xue L, Fleischer DE, Lu N, Dawsey SM, Wang GQ. Outcomes from a prospective trial of endoscopic radiofrequency ablation of early squamous cell neoplasia of the esophagus. Gastrointest Endosc. 2011;74:1181-1190. [PMID: 21839994 DOI: 10.1016/j.gie.2011.05.024] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 5.9] [Reference Citation Analysis]
156 Martinucci I, de Bortoli N, Russo S, Bertani L, Furnari M, Mokrowiecka A, Malecka-Panas E, Savarino V, Savarino E, Marchi S. Barrett’s esophagus in 2016: From pathophysiology to treatment. World J Gastrointest Pharmacol Ther 2016; 7(2): 190-206 [PMID: 27158534 DOI: 10.4292/wjgpt.v7.i2.190] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
157 Snider EJ, Compres G, Freedberg DE, Giddins MJ, Khiabanian H, Lightdale CJ, Nobel YR, Toussaint NC, Uhlemann AC, Abrams JA. Barrett's esophagus is associated with a distinct oral microbiome. Clin Transl Gastroenterol. 2018;9:135. [PMID: 29491399 DOI: 10.1038/s41424-018-0005-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
158 Rubenstein JH, Scheiman JM, Sadeghi S, Whiteman D, Inadomi JM. Esophageal adenocarcinoma incidence in individuals with gastroesophageal reflux: synthesis and estimates from population studies. Am J Gastroenterol 2011;106:254-60. [PMID: 21139576 DOI: 10.1038/ajg.2010.470] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 4.7] [Reference Citation Analysis]
159 Leggett CL, Prasad GA. High-grade dysplasia and intramucosal adenocarcinoma in Barrett’s esophagus: the role of endoscopic eradication therapy. Curr Opin Gastroenterol. 2012;28:354-361. [PMID: 22450896 DOI: 10.1097/mog.0b013e328352b78a] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
160 Choi SE, Perzan KE, Tramontano AC, Kong CY, Hur C. Statins and aspirin for chemoprevention in Barrett's esophagus: results of a cost-effectiveness analysis. Cancer Prev Res (Phila) 2014;7:341-50. [PMID: 24380852 DOI: 10.1158/1940-6207.CAPR-13-0191-T] [Cited by in Crossref: 21] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
161 Wei MT, Friedland S. Early Esophageal Cancer: What the Gastroenterologist Needs to Know. Gastroenterol Clin North Am 2021;50:791-808. [PMID: 34717871 DOI: 10.1016/j.gtc.2021.07.004] [Reference Citation Analysis]
162 Rajendra S, Sharma P. Management of Barrett's oesophagus and intramucosal oesophageal cancer: a review of recent development. Therap Adv Gastroenterol. 2012;5:285-299. [PMID: 22973415 DOI: 10.1177/1756283x12446668] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
163 Agarwal S, Alshelleh M, Scott J, Dhaliwal L, Codipilly DC, Dierkhising R, Leggett CL, Wang KK, Otaki FA, Trindade AJ, Iyer PG. Comparative outcomes of radiofrequency ablation and cryoballoon ablation in dysplastic Barrett's esophagus: a propensity score-matched cohort study. Gastrointest Endosc 2021:S0016-5107(21)01694-1. [PMID: 34624303 DOI: 10.1016/j.gie.2021.09.037] [Reference Citation Analysis]
164 Trindade AJ, Zhang J, Hauschild J, Leggett CL, Iyer PG. Impact of COVID-19 on the diagnosis and therapy for Barrett's esophagus and esophageal cancer in the United States. Gastroenterology 2021:S0016-5085(21)03796-3. [PMID: 34808138 DOI: 10.1053/j.gastro.2021.11.020] [Reference Citation Analysis]
165 Bornschein J, Fitzgerald RC. Barrett's oesophagus: diagnosis, surveillance and treatment. Br J Hosp Med (Lond) 2013;74:444-50. [PMID: 23958982 DOI: 10.12968/hmed.2013.74.8.444] [Reference Citation Analysis]
166 Zeki SS, Haidry R, Justo-Rodriguez M, Lovat LB, Wright NA, McDonald SA. Squamous cell carcinoma after radiofrequency ablation for Barrett's dysplasia. World J Gastroenterol 2014; 20(15): 4453-4456 [PMID: 24764687 DOI: 10.3748/wjg.v20.i15.4453] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
167 Sharma N, Ho KY. Management of Barrett's oesophagus. Br J Hosp Med (Lond) 2016;77:33-7. [PMID: 26903454 DOI: 10.12968/hmed.2016.77.1.33] [Reference Citation Analysis]
168 Liu JY, Liu BR. Minimally invasive treatments for Barrett's esophagus. Shijie Huaren Xiaohua Zazhi 2012; 20(36): 3707-3712 [DOI: 10.11569/wcjd.v20.i36.3707] [Reference Citation Analysis]
169 di Pietro M, Canto MI, Fitzgerald RC. Endoscopic Management of Early Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus: Screening, Diagnosis, and Therapy. Gastroenterology. 2018;154:421-436. [PMID: 28778650 DOI: 10.1053/j.gastro.2017.07.041] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 12.8] [Reference Citation Analysis]
170 Yachimski P, Peek RM Jr. Biomarkers in exploring the frontiers of diagnosis, prognosis, and therapy of Barrett's esophagus. Cancer Prev Res (Phila) 2011;4:783-6. [PMID: 21636544 DOI: 10.1158/1940-6207.CAPR-11-0204] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
171 Zhang Q, Agoston AT, Pham TH, Zhang W, Zhang X, Huo X, Peng S, Bajpai M, Das K, Odze RD, Spechler SJ, Souza RF. Acidic Bile Salts Induce Epithelial to Mesenchymal Transition via VEGF Signaling in Non-Neoplastic Barrett's Cells. Gastroenterology 2019;156:130-144.e10. [PMID: 30268789 DOI: 10.1053/j.gastro.2018.09.046] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
172 Shaheen NJ, Overholt BF, Sampliner RE, Wolfsen HC, Wang KK, Fleischer DE, Sharma VK, Eisen GM, Fennerty MB, Hunter JG, Bronner MP, Goldblum JR, Bennett AE, Mashimo H, Rothstein RI, Gordon SR, Edmundowicz SA, Madanick RD, Peery AF, Muthusamy VR, Chang KJ, Kimmey MB, Spechler SJ, Siddiqui AA, Souza RF, Infantolino A, Dumot JA, Falk GW, Galanko JA, Jobe BA, Hawes RH, Hoffman BJ, Sharma P, Chak A, Lightdale CJ. Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. Gastroenterology 2011;141:460-8. [PMID: 21679712 DOI: 10.1053/j.gastro.2011.04.061] [Cited by in Crossref: 317] [Cited by in F6Publishing: 256] [Article Influence: 28.8] [Reference Citation Analysis]
173 Whitson MJ, Falk GW. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus. Gastroenterol Clin North Am 2015;44:299-315. [PMID: 26021196 DOI: 10.1016/j.gtc.2015.02.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
174 Wartolowska K, Beard D, Carr A. Blinding in trials of interventional procedures is possible and worthwhile. F1000Res 2017;6:1663. [PMID: 29259763 DOI: 10.12688/f1000research.12528.2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
175 Sepulveda JL, Komissarova EV, Kongkarnka S, Friedman RA, Davison JM, Levy B, Bryk D, Jobanputra V, Del Portillo A, Falk GW, Sonett JR, Lightdale CJ, Abrams JA, Wang TC, Sepulveda AR. High-resolution genomic alterations in Barrett's metaplasia of patients who progress to esophageal dysplasia and adenocarcinoma. Int J Cancer 2019;145:2754-66. [PMID: 31001805 DOI: 10.1002/ijc.32351] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
176 Fang Y, Fang D, Hu J. MicroRNA and its roles in esophageal cancer. Med Sci Monit. 2012;18:RA22-RA30. [PMID: 22367141 DOI: 10.12659/msm.882509] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
177 Blum A, Chak A. FISH then grill? Using biomarkers to predict response to ablation. Gastrointest Endosc 2014;80:992-4. [PMID: 25434657 DOI: 10.1016/j.gie.2014.07.051] [Reference Citation Analysis]
178 Strauss AC, Agoston AT, Dulai PS, Srivastava A, Rothstein RI. Radiofrequency ablation for Barrett's-associated intramucosal carcinoma: a multi-center follow-up study. Surg Endosc. 2014;28:3366-3372. [PMID: 24950726 DOI: 10.1007/s00464-014-3629-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
179 Baldwin-Hunter BL, Knotts RM, Leeds SD, Rubenstein JH, Lightdale CJ, Abrams JA. Use of the Electronic Health Record to Target Patients for Non-endoscopic Barrett's Esophagus Screening. Dig Dis Sci 2019;64:3463-70. [PMID: 31273597 DOI: 10.1007/s10620-019-05707-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
180 Subramanian CR, Triadafilopoulos G. Radiofrequency-based treatments for esophageal disease. Eur Surg 2014;46:12-20. [DOI: 10.1007/s10353-013-0243-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
181 Lightdale CJ. A simpler way to do radiofrequency ablation for Barrett's oesophagus. Lancet Gastroenterol Hepatol 2018;3:525-6. [PMID: 29934225 DOI: 10.1016/S2468-1253(18)30174-2] [Reference Citation Analysis]
182 Eluri S, Shaheen NJ. Endoscopic Eradication Therapy in Barrett's Esophagus. Tech Gastrointest Endosc. 2017;19:137-142. [PMID: 29269998 DOI: 10.1016/j.tgie.2017.06.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
183 Lao-Sirieix P, Fitzgerald RC. Screening for oesophageal cancer. Nat Rev Clin Oncol. 2012;9:278-287. [PMID: 22430857 DOI: 10.1038/nrclinonc.2012.35] [Cited by in Crossref: 78] [Cited by in F6Publishing: 81] [Article Influence: 7.8] [Reference Citation Analysis]
184 Lewis JJ, Rubenstein JH, Singal AG, Elmunzer BJ, Kwon RS, Piraka CR. Factors associated with esophageal stricture formation after endoscopic mucosal resection for neoplastic Barrett’s esophagus. Gastrointest Endosc. 2011;74:753-760. [PMID: 21820109 DOI: 10.1016/j.gie.2011.05.031] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 4.4] [Reference Citation Analysis]
185 Bennett C, Moayyedi P, Corley DA, DeCaestecker J, Falck-Ytter Y, Falk G, Vakil N, Sanders S, Vieth M, Inadomi J. BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett’s Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. Am J Gastroenterol. 2015;110:662-682; quiz 683. [PMID: 25869390 DOI: 10.1038/ajg.2015.55] [Cited by in Crossref: 80] [Cited by in F6Publishing: 67] [Article Influence: 11.4] [Reference Citation Analysis]
186 Fitzgerald RC, di Pietro M, O'Donovan M, Maroni R, Muldrew B, Debiram-Beecham I, Gehrung M, Offman J, Tripathi M, Smith SG, Aigret B, Walter FM, Rubin G, Sasieni P; BEST3 Trial team. Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial. Lancet 2020;396:333-44. [PMID: 32738955 DOI: 10.1016/S0140-6736(20)31099-0] [Cited by in Crossref: 42] [Cited by in F6Publishing: 20] [Article Influence: 21.0] [Reference Citation Analysis]
187 Nieponice A, Badaloni AE, Jobe BA, Hoppo T, Pellegrini C, Velanovich V, Falk GW, Reavis K, Swanstrom L, Sharma VK, Nachman F, Ciotola FF, Caro LE, Cerisoli C, Cavadas D, Figueroa LD, Pirchi D, Gibson M, Elizalde S, Cohen H. Management of early-stage esophageal neoplasia (MESEN) consensus. World J Surg 2014;38:96-105. [PMID: 24101017 DOI: 10.1007/s00268-013-2235-y] [Reference Citation Analysis]
188 Bennett C, Green S, DeCaestecker J, Almond M, Barr H, Bhandari P, Ragunath K, Singh R, Jankowski J. Surgery versus radical endotherapies for early cancer and high-grade dysplasia in Barrett's oesophagus. Cochrane Database Syst Rev 2020;5:CD007334. [PMID: 32442322 DOI: 10.1002/14651858.CD007334.pub5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
189 Cameron GR, Desmond PV, Jayasekera CS, Amico F, Williams R, Macrae FA, Taylor AC. Recurrent intestinal metaplasia at the gastroesophageal junction following endoscopic eradication of dysplastic Barrett's esophagus may not be benign. Endosc Int Open 2016;4:E849-58. [PMID: 27540572 DOI: 10.1055/s-0042-109608] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
190 Whiteman DC. Esophageal Cancer: Priorities for Prevention. Curr Epidemiol Rep 2014;1:138-48. [DOI: 10.1007/s40471-014-0015-3] [Cited by in Crossref: 8] [Article Influence: 1.0] [Reference Citation Analysis]
191 De Silva N, Fitzgerald R. Barrett's oesophagus and oesophageal adenocarcinoma. Medicine 2015;43:202-9. [DOI: 10.1016/j.mpmed.2015.01.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
192 Morreale GC, Sinagra E, Vitello A, Shahini E, Shahini E, Maida M. Emerging artificial intelligence applications in gastroenterology: A review of the literature. Artif Intell Gastrointest Endosc 2020; 1(1): 6-18 [DOI: 10.37126/aige.v1.i1.6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
193 Naini BV, Souza RF, Odze RD. Barrett's Esophagus: A Comprehensive and Contemporary Review for Pathologists. Am J Surg Pathol. 2016;40:e45-e66. [PMID: 26813745 DOI: 10.1097/pas.0000000000000598] [Cited by in Crossref: 54] [Cited by in F6Publishing: 25] [Article Influence: 9.0] [Reference Citation Analysis]
194 Pasricha S, Cotton C, Hathorn KE, Li N, Bulsiewicz WJ, Wolf WA, Muthusamy VR, Komanduri S, Wolfsen HC, Pruitt RE, Ertan A, Chmielewski GW, Shaheen NJ. Effects of the Learning Curve on Efficacy of Radiofrequency Ablation for Barrett's Esophagus. Gastroenterology. 2015;149:890-6.e2. [PMID: 26116806 DOI: 10.1053/j.gastro.2015.06.012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
195 Raphael KL, Inamdar S, McKinley MJ, Martinez N, Cavaliere K, Kahn A, Leggett CL, Iyer P, Wang KK, Trindade AJ. Longitudinal and Circumferential Distributions of Dysplasia and Early Neoplasia in Barrett's Esophagus: A Pooled Analysis of Three Prospective Studies. Clin Transl Gastroenterol 2021;12:e00311. [PMID: 33617190 DOI: 10.14309/ctg.0000000000000311] [Reference Citation Analysis]
196 Morreale GC, Sinagra E, Vitello A, Shahini E, Shahini E, Maida M. Emerging artificia intelligence applications in gastroenterology: A review of the literature. AIGE 2020;1:19-27. [DOI: 10.37126/wjem.v1.i1.19] [Reference Citation Analysis]
197 Januszewicz W, Subhash VV, Waldock W, Fernando DI, Bartalucci G, Chettouh H, Miremadi A, O'Donovan M, Fitzgerald RC, di Pietro M. The utility of a methylation panel in the assessment of clinical response to radiofrequency ablation for Barrett's esophagus. EBioMedicine 2020;58:102877. [PMID: 32707444 DOI: 10.1016/j.ebiom.2020.102877] [Reference Citation Analysis]
198 Konda VJ, Dalal K. Optimal management of Barrett's esophagus: pharmacologic, endoscopic, and surgical interventions. Ther Clin Risk Manag 2011;7:447-58. [PMID: 22162921 DOI: 10.2147/TCRM.S23425] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
199 Suchniak-Mussari K, Dye CE, Moyer MT, Mathew A, McGarrity TJ, Gagliardi EM, Maranki JL, Levenick JM. Efficacy and safety of liquid nitrogen cryotherapy for treatment of Barrett’s esophagus. World J Gastrointest Endosc 2017; 9(9): 480-485 [PMID: 28979713 DOI: 10.4253/wjge.v9.i9.480] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
200 Johnson CS, Louie BE, Wille A, Dunst CM, Worrell SG, DeMeester SR, Reynolds J, Dixon J, Lipham JC, Lada M, Peters JH, Watson TJ, Farivar AS, Aye RW. The Durability of Endoscopic Therapy for Treatment of Barrett's Metaplasia, Dysplasia, and Mucosal Cancer After Nissen Fundoplication. J Gastrointest Surg. 2015;19:799-805. [PMID: 25740341 DOI: 10.1007/s11605-015-2783-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
201 Eluri S, Earasi AG, Moist SE, Dellon ES, Shaheen NJ. Prevalence and Incidence of Intestinal Metaplasia and Dysplasia of Gastric Cardia in Patients With Barrett's Esophagus After Endoscopic Therapy. Clin Gastroenterol Hepatol 2020;18:82-88.e1. [PMID: 31077822 DOI: 10.1016/j.cgh.2019.04.065] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
202 Blevins CH, Egginton JS, Shah ND, Johnson ML, Iyer PG. Comparative Assessment of Patient Preferences and Tolerability in Barrett Esophagus Screening: Results From a Randomized Trial. J Clin Gastroenterol. 2018;52:880-884. [PMID: 29369237 DOI: 10.1097/mcg.0000000000000991] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
203 Kim MP, Brown KN, Schwartz MR, Blackmon SH. Advanced esophageal cancer in patients who underwent radiofrequency ablation for barrett esophagus with high-grade dysplasia. Innovations (Phila) 2013;8:17-22. [PMID: 23571789 DOI: 10.1097/IMI.0b013e31828db550] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
204 Butt J, Kandel G. Barrett esophagus: when to endoscope. Clin Endosc 2014;47:40-6. [PMID: 24570882 DOI: 10.5946/ce.2014.47.1.40] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
205 Semlitsch T, Jeitler K, Schoefl R, Horvath K, Pignitter N, Harnoncourt F, Siebenhofer A. A systematic review of the evidence for radiofrequency ablation for Barrett's esophagus. Surg Endosc. 2010;24:2935-2943. [PMID: 20464420 DOI: 10.1007/s00464-010-1087] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
206 Rouphael C, Anil Kumar M, Sanaka MR, Thota PN. Indications, contraindications and limitations of endoscopic therapy for Barrett's esophagus and early esophageal adenocarcinoma. Therap Adv Gastroenterol 2020;13:1756284820924209. [PMID: 32523628 DOI: 10.1177/1756284820924209] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
207 Ortiz-Fernández-Sordo J, Parra-Blanco A, García-Varona A, Rodríguez-Peláez M, Madrigal-Hoyos E, Waxman I, Rodrigo L. Endoscopic resection techniques and ablative therapies for Barrett’s neoplasia. World J Gastrointest Endosc 2011; 3(9): 171-182 [PMID: 21954414 DOI: 10.4253/wjge.v3.i9.171] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
208 Kumar S, Iyer PG. Endoscopic eradication therapy for Barrett’s esophagus: Adverse outcomes, patient values, and cost-effectiveness. Techniques in Gastrointestinal Endoscopy 2018;20:75-81. [DOI: 10.1016/j.tgie.2018.02.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
209 Schoppmann SF, Kristo I, Riegler M. Does anti-reflux surgery disrupt the pathway of Barrett's esophagus progression to cancer? Transl Gastroenterol Hepatol 2018;3:101. [PMID: 30701208 DOI: 10.21037/tgh.2018.11.07] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
210 Reed CC, Shaheen NJ. Endoscopic Treatment of High-Grade Dysplasia and Intramucosal Esophageal Adenocarcinoma. J Laparoendosc Adv Surg Tech A 2016;26:768-72. [PMID: 27541732 DOI: 10.1089/lap.2016.29012.ccr] [Reference Citation Analysis]
211 Ramay FH, Cui Q, Greenwald BD. Outcomes after liquid nitrogen spray cryotherapy in Barrett's esophagus-associated high-grade dysplasia and intramucosal adenocarcinoma: 5-year follow-up. Gastrointest Endosc. 2017;86:626-632. [PMID: 28235596 DOI: 10.1016/j.gie.2017.02.006] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 7.6] [Reference Citation Analysis]
212 Garman KS, Shaheen NJ. Ablative therapies for Barrett's esophagus. Curr Gastroenterol Rep 2011;13:226-39. [PMID: 21373836 DOI: 10.1007/s11894-011-0182-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
213 Nelsen EM, Hawes RH, Iyer PG. Diagnosis and management of Barrett’s esophagus. Surg Clin North Am. 2012;92:1135-1154. [PMID: 23026274 DOI: 10.1016/j.suc.2012.07.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
214 Fujii-Lau LL, Cinnor B, Shaheen N, Gaddam S, Komanduri S, Muthusamy VR, Das A, Wilson R, Simon VC, Kushnir V, Mullady D, Edmundowicz SA, Early DS, Wani S. Recurrence of intestinal metaplasia and early neoplasia after endoscopic eradication therapy for Barrett's esophagus: a systematic review and meta-analysis. Endosc Int Open 2017;5:E430-49. [PMID: 28573176 DOI: 10.1055/s-0043-106578] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
215 Bulsiewicz WJ, Dellon ES, Rogers AJ, Pasricha S, Madanick RD, Grimm IS, Shaheen NJ. The impact of endoscopic ultrasound findings on clinical decision making in Barrett’s esophagus with high-grade dysplasia or early esophageal adenocarcinoma. Dis Esophagus. 2014;27:409-417. [PMID: 23016606 DOI: 10.1111/j.1442-2050.2012.01408.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
216 Marabotto E, Pellegatta G, Sheijani AD, Ziola S, Zentilin P, De Marzo MG, Giannini EG, Ghisa M, Barberio B, Scarpa M, Angriman I, Fassan M, Savarino V, Savarino E. Prevention Strategies for Esophageal Cancer-An Expert Review. Cancers (Basel) 2021;13:2183. [PMID: 34062788 DOI: 10.3390/cancers13092183] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
217 Wang KK. Ablation is in the eye of the beholder. Clin Gastroenterol Hepatol 2013;11:643-4. [PMID: 23524127 DOI: 10.1016/j.cgh.2013.02.028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
218 Oda M, Kalloo A, Mizukami K, Murakami K, Sawa A. Endoscopy and Barrett's Esophagus: Current Perspectives in the US and Japan. Intern Med 2021;60:327-35. [PMID: 32863360 DOI: 10.2169/internalmedicine.4400-19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
219 Yachimski P, Wani S, Givens T, Howard E, Higginbotham T, Price A, Berman K, Hosford L, Katcher PM, Ozanne E. Preference of endoscopic ablation over medical prevention of esophageal adenocarcinoma by patients with Barrett’s esophagus. Clin Gastroenterol Hepatol. 2015;13:84-90. [PMID: 24681073 DOI: 10.1016/j.cgh.2014.03.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
220 Haidry RJ, Butt MA, Dunn JM, Gupta A, Lipman G, Smart HL, Bhandari P, Smith L, Willert R, Fullarton G, Di Pietro M, Gordon C, Penman I, Barr H, Patel P, Kapoor N, Hoare J, Narayanasamy R, Ang Y, Veitch A, Ragunath K, Novelli M, Lovat LB; UK RFA Registry. Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett's oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registry. Gut 2015;64:1192-9. [PMID: 25539672 DOI: 10.1136/gutjnl-2014-308501] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 7.4] [Reference Citation Analysis]
221 Kolb JM, Wani S. Endoscopic Management of Barrett's Esophagus. Dig Dis Sci 2022. [PMID: 35226224 DOI: 10.1007/s10620-022-07395-x] [Reference Citation Analysis]
222 O'Donovan M, Fitzgerald RC. Screening for Barrett's Esophagus: Are New High-Volume Methods Feasible? Dig Dis Sci 2018;63:2105-14. [PMID: 29995243 DOI: 10.1007/s10620-018-5192-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
223 Quante M, Abrams JA, Lee Y, Wang TC. Barrett esophagus: what a mouse model can teach us about human disease. Cell Cycle. 2012;11:4328-4338. [PMID: 23095673 DOI: 10.4161/cc.22485] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
224 Bhardwaj A, McGarrity TJ, Stairs DB, Mani H. Barrett's Esophagus: Emerging Knowledge and Management Strategies. Patholog Res Int. 2012;2012:814146. [PMID: 22701199 DOI: 10.1155/2012/814146] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
225 Londono R, Jobe BA, Hoppo T, Badylak SF. Esophagus and regenerative medicine. World J Gastroenterol 2012; 18(47): 6894-6899 [PMID: 23322986 DOI: 10.3748/wjg.v18.i47.6894] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
226 Zaninotto G, Hunter JG. Dysplastic Barrett's esophagus. World J Surg 2015;39:557-8. [PMID: 25002243 DOI: 10.1007/s00268-014-2681-1] [Reference Citation Analysis]
227 de Caestecker J, Barr H, Bhandari P, Lovat L, Peerally MF, Ragunath K, Smart H. Randomized studies for Barrett's ablation: identifying the most cost-effective solutions by keeping an open mind. Gastrointest Endosc 2020;91:1218-20. [PMID: 32327125 DOI: 10.1016/j.gie.2020.01.019] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
228 Watson TJ. Endoscopic therapies for Barrett's neoplasia. J Thorac Dis 2014;6 Suppl 3:S298-308. [PMID: 24876934 DOI: 10.3978/j.issn.2072-1439.2014.03.35] [Reference Citation Analysis]
229 Shaheen NJ, Komanduri S, Muthusamy VR, Wani S, O'Donovan M, Kaushal R, Haydek JM. Acceptability and Adequacy of a Non-endoscopic Cell Collection Device for Diagnosis of Barrett's Esophagus: Lessons Learned. Dig Dis Sci 2021. [PMID: 33532971 DOI: 10.1007/s10620-021-06833-6] [Reference Citation Analysis]
230 Skrobić O, Simić A, Radovanović N, Ivanović N, Micev M, Peško P. Significance of Nissen fundoplication after endoscopic radiofrequency ablation of Barrett's esophagus. Surg Endosc 2016;30:3802-7. [PMID: 26659238 DOI: 10.1007/s00464-015-4677-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
231 Semlitsch T, Jeitler K, Schoefl R, Horvath K, Pignitter N, Harnoncourt F, Siebenhofer A. A systematic review of the evidence for radiofrequency ablation for Barrett’s esophagus. Surg Endosc. 2010;24:2935-2943. [PMID: 20464420 DOI: 10.1007/s00464-010-1087-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
232 Chen M, Dang Y, Ding C, Yang J, Si X, Zhang G. Lesion size and circumferential range identified as independent risk factors for esophageal stricture after endoscopic submucosal dissection. Surg Endosc 2020;34:4065-71. [PMID: 31953729 DOI: 10.1007/s00464-020-07368-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
233 Markar SR, Hanna G. Minimally invasive esophagectomy for dysplastic Barrett's esophagus. World J Surg 2015;39:608-14. [PMID: 25145822 DOI: 10.1007/s00268-014-2746-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
234 Kobayashi S, Kanai N, Ohki T, Takagi R, Yamaguchi N, Isomoto H, Kasai Y, Hosoi T, Nakao K, Eguchi S, Yamamoto M, Yamato M, Okano T. Prevention of esophageal strictures after endoscopic submucosal dissection. World J Gastroenterol 2014; 20(41): 15098-15109 [PMID: 25386058 DOI: 10.3748/wjg.v20.i41.15098] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
235 Rajendra S, Sharma P. Barrett's Esophagus. Curr Treat Options Gastroenterol 2014;12:169-82. [PMID: 24634008 DOI: 10.1007/s11938-014-0012-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
236 Vance RB, Dunbar KB. Endoscopic options for treatment of dysplasia in Barrett’s esophagus. World J Gastrointest Endosc 2015; 7(19): 1311-1317 [PMID: 26722612 DOI: 10.4253/wjge.v7.i19.1311] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
237 Pioche M, O'Brien M, Rivory J. Please provide us with a reasonable definition for curative R0 resection in Barrett's esophagus neoplasia; which one should we choose? Endosc Int Open 2015;3:E566-8. [PMID: 26716113 DOI: 10.1055/s-0034-1392648] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
238 Kadri SR, Lao-Sirieix P, O’Donovan M, Debiram I, Das M, Blazeby JM, Emery J, Boussioutas A, Morris H, Walter FM. Acceptability and accuracy of a non-endoscopic screening test for Barrett’s oesophagus in primary care: cohort study. BMJ. 2010;341:c4372. [PMID: 20833740 DOI: 10.1136/bmj.c4372] [Cited by in Crossref: 201] [Cited by in F6Publishing: 188] [Article Influence: 16.8] [Reference Citation Analysis]
239 Furneri G, Klausnitzer R, Haycock L, Ihara Z. Economic value of narrow-band imaging versus white light endoscopy for the diagnosis and surveillance of Barrett's esophagus: Cost-consequence model. PLoS One 2019;14:e0212916. [PMID: 30865673 DOI: 10.1371/journal.pone.0212916] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
240 Smyth EC, Cunningham D. Operable gastro-oesophageal junctional adenocarcinoma: Where to next? World J Gastrointest Oncol 2014; 6(6): 145-155 [PMID: 24936225 DOI: 10.4251/wjgo.v6.i6.145] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
241 Solomon BL, Garrido-Laguna I. Upper gastrointestinal malignancies in 2017: current perspectives and future approaches. Future Oncol 2018;14:947-62. [PMID: 29542354 DOI: 10.2217/fon-2017-0597] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
242 Singh T, Sanghi V, Thota PN. Current management of Barrett esophagus and esophageal adenocarcinoma. Cleve Clin J Med 2019;86:724-32. [PMID: 31710585 DOI: 10.3949/ccjm.86a.18106] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
243 Noordzij IC, Curvers WL, Schoon EJ. Endoscopic resection for early esophageal carcinoma. J Thorac Dis 2019;11:S713-22. [PMID: 31080649 DOI: 10.21037/jtd.2019.03.19] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
244 Ishihara R, Yamamoto S, Hanaoka N, Takeuchi Y, Higashino K, Uedo N, Iishi H. Endoscopic submucosal dissection for superficial Barrett's esophageal cancer in the Japanese state and perspective. Ann Transl Med 2014;2:24. [PMID: 25333000 DOI: 10.3978/j.issn.2305-5839.2014.02.03] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
245 Visrodia K, Zakko L, Wang KK. Mucosal Ablation in Patients with Barrett's Esophagus: Fry or Freeze? Dig Dis Sci 2018;63:2129-35. [PMID: 29777441 DOI: 10.1007/s10620-018-5064-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
246 Everson M, Magee C, Alzoubaidi D, Brogden S, Graham D, Lovat LB, Novelli M, Haidry R. Minichromosomal Maintenance Component Complex 5 (MCM5) as a Marker of Barrett's Esophagus-Related Neoplasia: A Feasibility Study. Dig Dis Sci 2019;64:2815-22. [PMID: 30982210 DOI: 10.1007/s10620-019-05607-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
247 Nieponice A, Nachman F, Badaloni A, Ciotola F, Zubieta C, Ramirez M. The impact of flexible endoscopy in esophageal surgery. J Thorac Dis 2017;9:S681-8. [PMID: 28815063 DOI: 10.21037/jtd.2017.05.61] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
248 Wang Y, Ma B, Yang S, Li W, Li P. Efficacy and Safety of Radiofrequency Ablation vs. Endoscopic Surveillance for Barrett’s Esophagus With Low-Grade Dysplasia: Meta-Analysis of Randomized Controlled Trials. Front Oncol 2022;12:801940. [DOI: 10.3389/fonc.2022.801940] [Reference Citation Analysis]
249 Chu KK, Zhao Y, Jelly ET, Steelman ZA, Crose M, Cox B, Ofori-Marfoh Y, Moussa L, Cirri H, Watts A, Shaheen N, Wax A. Esophageal OCT Imaging Using a Paddle Probe Externally Attached to Endoscope. Dig Dis Sci 2022. [PMID: 35084606 DOI: 10.1007/s10620-021-07372-w] [Reference Citation Analysis]
250 Kamboj AK, Katzka DA, Iyer PG. Endoscopic Screening for Barrett's Esophagus and Esophageal Adenocarcinoma: Rationale, Candidates, and Challenges. Gastrointest Endosc Clin N Am 2021;31:27-41. [PMID: 33213798 DOI: 10.1016/j.giec.2020.08.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
251 Zhang YM, Bergman JJ, Weusten B, Dawsey SM, Fleischer DE, Lu N, He S, Wang GQ. Radiofrequency ablation for early esophageal squamous cell neoplasia. Endoscopy 2010;42:327-33. [PMID: 20235007 DOI: 10.1055/s-0029-1244017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
252 Barret M, Prat F. Diagnosis and treatment of superficial esophageal cancer. Ann Gastroenterol. 2018;31:256-265. [PMID: 29720850 DOI: 10.20524/aog.2018.0252] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
253 Januszewicz W, Tan WK, Lehovsky K, Debiram-Beecham I, Nuckcheddy T, Moist S, Kadri S, di Pietro M, Boussioutas A, Shaheen NJ, Katzka DA, Dellon ES, Fitzgerald RC; BEST1 and BEST2 study investigators. Safety and Acceptability of Esophageal Cytosponge Cell Collection Device in a Pooled Analysis of Data From Individual Patients. Clin Gastroenterol Hepatol. 2019;17:647-656.e1. [PMID: 30099104 DOI: 10.1016/j.cgh.2018.07.043] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 7.3] [Reference Citation Analysis]
254 van Munster SN, Nieuwenhuis EA, Weusten BLAM, Herrero LA, Bogte A, Alkhalaf A, Schenk BE, Schoon EJ, Curvers W, Koch AD, van de Ven SEM, de Jonge PJF, Tang T, Nagengast WB, Peters FTM, Westerhof J, Houben MHMG, Bergman JJGHM, Pouw RE; Dutch Barrett Expert Centers. Endoscopic Resection Without Subsequent Ablation Therapy for Early Barrett's Neoplasia: Endoscopic Findings and Long-Term Mortality. J Gastrointest Surg 2021;25:67-76. [PMID: 33140322 DOI: 10.1007/s11605-020-04836-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
255 Marks JM, King AJ. Current status of management of malignant disease: what are the options for premalignant lesions of the esophagus and stomach? J Gastrointest Surg 2015;19:575-8. [PMID: 25394385 DOI: 10.1007/s11605-014-2677-z] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
256 Fang T, Xiao J, Zhang Y, Hu H, Zhu Y, Cheng Y. Combined with interventional therapy, immunotherapy can create a new outlook for tumor treatment. Quant Imaging Med Surg 2021;11:2837-60. [PMID: 34079746 DOI: 10.21037/qims-20-173] [Reference Citation Analysis]
257 Yasuda K, Choi SE, Nishioka NS, Rattner DW, Puricelli WP, Tramontano AC, Kitano S, Hur C. Incidence and predictors of adenocarcinoma following endoscopic ablation of Barrett's esophagus. Dig Dis Sci 2014;59:1560-6. [PMID: 24395382 DOI: 10.1007/s10620-013-3002-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
258 Sappati Biyyani RS, Chak A. Barrett's esophagus: review of diagnosis and treatment. Gastroenterol Rep (Oxf) 2013;1:9-18. [PMID: 24759662 DOI: 10.1093/gastro/got015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
259 Snyder P, Dunbar K, Cipher DJ, Souza RF, Spechler SJ, Konda VJA. Aberrant p53 Immunostaining in Barrett's Esophagus Predicts Neoplastic Progression: Systematic Review and Meta-Analyses. Dig Dis Sci 2019;64:1089-97. [PMID: 30911864 DOI: 10.1007/s10620-019-05586-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
260 Shaheen NJ, Peery AF, Hawes RH, Rothstein RI, Spechler SJ, Galanko JA, Campbell M, Carr C, Fowler B, Walsh J, Siddiqui AA, Infantolino A, Wolfsen HC; AIM Dysplasia Trial Investigators. Quality of life following radiofrequency ablation of dysplastic Barrett's esophagus. Endoscopy. 2010;42:790-799. [PMID: 20886398 DOI: 10.1055/s-0030-1255780] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
261 Sato F, Kubota Y, Natsuizaka M, Maehara O, Hatanaka Y, Marukawa K, Terashita K, Suda G, Ohnishi S, Shimizu Y, Komatsu Y, Ohashi S, Kagawa S, Kinugasa H, Whelan KA, Nakagawa H, Sakamoto N. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition. Cancer Biol Ther 2015;16:933-40. [PMID: 25897987 DOI: 10.1080/15384047.2015.1040959] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
262 Yachimski P, Shi C, Slaughter JC, Washington MK. Endoscopic mucosal resection of Barrett’s esophagus detects high prevalence of subsquamous intestinal metaplasia. World J Gastrointest Endosc 2013; 5(12): 590-594 [PMID: 24368934 DOI: 10.4253/wjge.v5.i12.590] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
263 Kajzrlikova I, Vitek P, Falt P, Urban O, Kominek P. Recurrent oesophageal intramucosal squamous carcinoma treated by endoscopic mucosal resection and subsequent radiofrequency ablation using HALO system. BMJ Case Rep 2010;2010:bcr0820103211. [PMID: 22802374 DOI: 10.1136/bcr.08.2010.3211] [Reference Citation Analysis]
264 Yang CS, Chen X, Tu S. Etiology and Prevention of Esophageal Cancer. Gastrointest Tumors. 2016;3:3-16. [PMID: 27722152 DOI: 10.1159/000443155] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 6.8] [Reference Citation Analysis]
265 Konda VJA, Souza RF. Biomarkers of Barrett's Esophagus: From the Laboratory to Clinical Practice. Dig Dis Sci. 2018;63:2070-2080. [PMID: 29713984 DOI: 10.1007/s10620-018-5088-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
266 Mizrahi M, Sengupta N, Pleskow DK, Chuttani R, Sawhney MS, Berzin TM. Minor Anesthesia-Related Events During Radiofrequency Ablation for Barrett's Esophagus Are Associated with an Increased Number of Treatment Sessions. Dig Dis Sci 2016;61:1591-6. [PMID: 26894399 DOI: 10.1007/s10620-016-4059-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
267 Ayers K, Shi C, Washington K, Yachimski P. Expert pathology review and endoscopic mucosal resection alters the diagnosis of patients referred to undergo therapy for Barrett's esophagus. Surg Endosc 2013;27:2836-40. [PMID: 23389078 DOI: 10.1007/s00464-013-2830-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
268 Kallam A, Alsop BR, Sharma P. Limitations of endoscopic ablation in Barrett's esophagus. Expert Rev Gastroenterol Hepatol 2015;9:487-96. [PMID: 25483982 DOI: 10.1586/17474124.2015.976554] [Reference Citation Analysis]
269 Maresso KC, Tsai KY, Brown PH, Szabo E, Lippman S, Hawk ET. Molecular cancer prevention: Current status and future directions. CA Cancer J Clin 2015;65:345-83. [PMID: 26284997 DOI: 10.3322/caac.21287] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 6.1] [Reference Citation Analysis]
270 Nelsen EM, Hawes RH, Iyer PG. Diagnosis and management of Barrett's esophagus. Surg Clin North Am 2012;92:1135-54. [PMID: 23026274 DOI: 10.1016/j.suc.2012.07.009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
271 Rappaport J, Raja S. Commentary: Age is just a number: Let's give endoscopy a chance in the treatment of early esophageal cancer. J Thorac Cardiovasc Surg 2020;160:304-5. [PMID: 32029212 DOI: 10.1016/j.jtcvs.2019.12.046] [Reference Citation Analysis]
272 Palma GDD. Management strategies of Barrett's esophagus. World J Gastroenterol 2012; 18(43): 6216-6225 [PMID: 23180941 DOI: 10.3748/wjg.v18.i43.6216] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
273 Azarm A, Lukolic I, Shukla M, Concha-Parra R, Gress F. Endoscopic management of Barrett's esophagus: advances in endoscopic techniques. Dig Dis Sci 2012;57:3055-64. [PMID: 22760590 DOI: 10.1007/s10620-012-2279-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
274 Elimova E, Mizrak Kaya D, Harada K, Ajani JA. Potentially Curable Cancers of the Esophagus and Stomach. Mayo Clin Proc 2016;91:1307-18. [PMID: 27594190 DOI: 10.1016/j.mayocp.2016.07.018] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
275 Zhang LY, Kalloo AN, Ngamruengphong S. Therapeutic Endoscopy and the Esophagus: State of the Art and Future Directions. Gastroenterol Clin North Am 2021;50:935-58. [PMID: 34717880 DOI: 10.1016/j.gtc.2021.08.007] [Reference Citation Analysis]
276 Visrodia K, Zakko L, Singh S, Leggett CL, Iyer PG, Wang KK. Cryotherapy for persistent Barrett's esophagus after radiofrequency ablation: a systematic review and meta-analysis. Gastrointest Endosc 2018;87:1396-1404.e1. [PMID: 29476849 DOI: 10.1016/j.gie.2018.02.021] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
277 Vienne A, Prat F. [Endoscopic treatments for Barrett oesophagus]. Presse Med 2011;40:516-28. [PMID: 21474270 DOI: 10.1016/j.lpm.2011.02.022] [Reference Citation Analysis]
278 Witteman BP, Foxwell TJ, Monsheimer S, Gelrud A, Eid GM, Nieponice A, O'Rourke RW, Hoppo T, Bouvy ND, Badylak SF, Jobe BA. Transoral endoscopic inner layer esophagectomy: management of high-grade dysplasia and superficial cancer with organ preservation. J Gastrointest Surg 2009;13:2104-12. [PMID: 19826883 DOI: 10.1007/s11605-009-1053-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
279 Grimm JC, Valero V, Molena D. Surgical indications and optimization of patients for resectable esophageal malignancies. J Thorac Dis. 2014;6:249-257. [PMID: 24624289 DOI: 10.3978/j.issn.2072-1439.2013.11.18] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
280 Akiyama J, Roorda A, Triadafilopoulos G. Managing Barrett's esophagus with radiofrequency ablation. Gastroenterol Rep (Oxf) 2013;1:95-104. [PMID: 24759814 DOI: 10.1093/gastro/got009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
281 Milind R, Attwood SE. Natural history of Barrett's esophagus. World J Gastroenterol 2012; 18(27): 3483-3491 [PMID: 22826612 DOI: 10.3748/wjg.v18.i27.3483] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
282 Menon D, Stafinski T, Wu H, Lau D, Wong C. Endoscopic treatments for Barrett's esophagus: a systematic review of safety and effectiveness compared to esophagectomy. BMC Gastroenterol 2010;10:111. [PMID: 20875123 DOI: 10.1186/1471-230X-10-111] [Cited by in Crossref: 39] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
283 Wax A, Terry NG, Dellon ES, Shaheen NJ. Angle-resolved low coherence interferometry for detection of dysplasia in Barrett’s esophagus. Gastroenterology. 2011;141:443-447, 447.e1-2. [PMID: 21703265 DOI: 10.1053/j.gastro.2011.06.020] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
284 Fornari F, Wagner R. Update on endoscopic diagnosis, management and surveillance strategies of esophageal diseases. World J Gastrointest Endosc 2012; 4(4): 117-122 [PMID: 22523612 DOI: 10.4253/wjge.v4.i4.117] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
285 Pasricha S, Bulsiewicz WJ, Hathorn KE, Komanduri S, Muthusamy VR, Rothstein RI, Wolfsen HC, Lightdale CJ, Overholt BF, Camara DS. Durability and predictors of successful radiofrequency ablation for Barrett’s esophagus. Clin Gastroenterol Hepatol. 2014;12:1840-7.e1. [PMID: 24815329 DOI: 10.1016/j.cgh.2014.04.034] [Cited by in Crossref: 77] [Cited by in F6Publishing: 66] [Article Influence: 9.6] [Reference Citation Analysis]
286 Pasricha S, Li N, Bulsiewicz WJ, Rothstein RI, Infantolino A, Ertan A, Camara DS, Dellon ES, Triadafilopoulos G, Lightdale CJ, Madanick RD, Lyday WD, Muthusamy RV, Overholt BF, Shaheen NJ. Sex and race and/or ethnicity differences in patients undergoing radiofrequency ablation for Barrett's esophagus: results from the U.S. RFA Registry. Gastrointest Endosc. 2015;82:276-284. [PMID: 25841575 DOI: 10.1016/j.gie.2015.01.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
287 Ventre S, Shahid H. Endoscopic therapies for Barrett's esophagus. Transl Gastroenterol Hepatol 2021;6:62. [PMID: 34805584 DOI: 10.21037/tgh.2020.02.04] [Reference Citation Analysis]
288 Gilbert EW, Luna RA, Harrison VL, Hunter JG. Barrett’s esophagus: a review of the literature. J Gastrointest Surg. 2011;15:708-718. [PMID: 21461873 DOI: 10.1007/s11605-011-1485-y] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
289 Greenwald BD, Lightdale CJ, Abrams JA, Horwhat JD, Chuttani R, Komanduri S, Upton MP, Appelman HD, Shields HM, Shaheen NJ, Sontag SJ. Barrett's esophagus: endoscopic treatments II. Ann N Y Acad Sci 2011;1232:156-74. [PMID: 21950812 DOI: 10.1111/j.1749-6632.2011.06050.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
290 Haidry RJ, Butt MA, Dunn J, Banks M, Gupta A, Smart H, Bhandari P, Smith LA, Willert R, Fullarton G, John M, Pietro MD, Penman I, Novelli M, Lovat LB. Radiofrequency ablation for early oesophageal squamous neoplasia: Outcomes form United Kingdom registry. World J Gastroenterol 2013; 19(36): 6011-6019 [PMID: 24106401 DOI: 10.3748/wjg.v19.i36.6011] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
291 Oumrani S, Barret M, Beuvon F, Leblanc S, Chaussade S, Prat F. Salvage endoscopic submucosal dissection for esophageal adenocarcinoma arising during radiofrequency ablation. Ann Gastroenterol 2018;31:522-4. [PMID: 29991901 DOI: 10.20524/aog.2018.0261] [Reference Citation Analysis]
292 Yano T, Minamide T, Takashima K, Nakajo K, Kadota T, Yoda Y. Clinical Practice of Photodynamic Therapy Using Talaporfin Sodium for Esophageal Cancer. J Clin Med 2021;10:2785. [PMID: 34202917 DOI: 10.3390/jcm10132785] [Reference Citation Analysis]
293 Lenglinger J, See SF, Beller L, Cosentini EP, Asari R, Wrba F, Riegler M, Schoppmann SF. Review on novel concepts of columnar lined esophagus. Wien Klin Wochenschr 2013;125:577-90. [PMID: 24061694 DOI: 10.1007/s00508-013-0418-z] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
294 Stier MW, Konda VJ, Hart J, Waxman I. Post-ablation surveillance in Barrett's esophagus: A review of the literature. World J Gastroenterol 2016; 22(17): 4297-4306 [PMID: 27158198 DOI: 10.3748/wjg.v22.i17.4297] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
295 Canto MI, Anandasabapathy S, Brugge W, Falk GW, Dunbar KB, Zhang Z, Woods K, Almario JA, Schell U, Goldblum J. In vivo endomicroscopy improves detection of Barrett’s esophagus-related neoplasia: a multicenter international randomized controlled trial (with video). Gastrointest Endosc. 2014;79:211-221. [PMID: 24219822 DOI: 10.1016/j.gie.2013.09.020] [Cited by in Crossref: 133] [Cited by in F6Publishing: 100] [Article Influence: 14.8] [Reference Citation Analysis]
296 Fudman DI, Lightdale CJ, Poneros JM, Ginsberg GG, Falk GW, Demarshall M, Gupta M, Iyer PG, Lutzke L, Wang KK, Abrams JA. Positive correlation between endoscopist radiofrequency ablation volume and response rates in Barrett's esophagus. Gastrointest Endosc. 2014;80:71-77. [PMID: 24565071 DOI: 10.1016/j.gie.2014.01.007] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
297 Gan P, Fan W, Zhang H, Zhong C, Xia H, Lü M, Zhou X, Tang X. The Top-Cited Articles With a Focus on Barrett's Esophagus: A Bibliometric Analysis. Front Surg 2022;9:743274. [DOI: 10.3389/fsurg.2022.743274] [Reference Citation Analysis]
298 Lei S, Mulmi Shrestha S, Shi R. Radiofrequency Ablation for Early Superficial Flat Esophageal Squamous Cell Neoplasia: A Comprehensive Review. Gastroenterol Res Pract 2020;2020:4152453. [PMID: 32508911 DOI: 10.1155/2020/4152453] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
299 Parasa S, Sharma P. Measuring quality of endoscopic eradication therapy in Barrett's esophagus. Gastrointest Endosc 2016;83:743-5. [PMID: 26975281 DOI: 10.1016/j.gie.2015.12.026] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
300 Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ; American Gastroenterological Association. American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology. 2011;140:e18-52; quiz e13. [PMID: 21376939 DOI: 10.1053/j.gastro.2011.01.031] [Cited by in Crossref: 766] [Cited by in F6Publishing: 517] [Article Influence: 69.6] [Reference Citation Analysis]
301 Muñoz-Largacha JA, Litle VR. Endoscopic mucosal ablation and resection of Barrett's esophagus and related diseases. J Vis Surg 2017;3:128. [PMID: 29078688 DOI: 10.21037/jovs.2017.07.10] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
302 Old OJ, Almond LM, Barr H. Barrett's oesophagus: how should we manage it? Frontline Gastroenterol 2015;6:108-16. [PMID: 28839797 DOI: 10.1136/flgastro-2014-100552] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
303 Lee HC, Ahsen OO, Liu JJ, Tsai TH, Huang Q, Mashimo H, Fujimoto JG. Assessment of the radiofrequency ablation dynamics of esophageal tissue with optical coherence tomography. J Biomed Opt. 2017;22:76001. [PMID: 28687822 DOI: 10.1117/1.jbo.22.7.076001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
304 Killcoyne S, Fitzgerald RC. Evolution and progression of Barrett's oesophagus to oesophageal cancer. Nat Rev Cancer 2021;21:731-41. [PMID: 34545238 DOI: 10.1038/s41568-021-00400-x] [Reference Citation Analysis]
305 Suarez AL, Coté GA, Elmunzer BJ. Adjunctive radiofrequency ablation for the endoscopic treatment of ampullary lesions with intraductal extension (with video). Endosc Int Open 2016;4:E748-51. [PMID: 27556089 DOI: 10.1055/s-0042-107665] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
306 Small AJ, Araujo JL, Leggett CL, Mendelson AH, Agarwalla A, Abrams JA, Lightdale CJ, Wang TC, Iyer PG, Wang KK, Rustgi AK, Ginsberg GG, Forde KA, Gimotty PA, Lewis JD, Falk GW, Bewtra M. Radiofrequency Ablation Is Associated With Decreased Neoplastic Progression in Patients With Barrett's Esophagus and Confirmed Low-Grade Dysplasia. Gastroenterology. 2015;149:567-76.e3; quiz e13-4. [PMID: 25917785 DOI: 10.1053/j.gastro.2015.04.013] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 7.0] [Reference Citation Analysis]
307 Inayat F, Weissman S, Malik A, Munir B, Iqbal S. Endoscopic Submucosal Tunnel Dissection as a Novel Therapeutic Technique in Patients With Barrett's Esophagus. J Investig Med High Impact Case Rep 2020;8:2324709620941318. [PMID: 32666847 DOI: 10.1177/2324709620941318] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
308 Li N, Pasricha S, Bulsiewicz WJ, Pruitt RE, Komanduri S, Wolfsen HC, Chmielewski GW, Corbett FS, Chang KJ, Shaheen NJ. Effects of preceding endoscopic mucosal resection on the efficacy and safety of radiofrequency ablation for treatment of Barrett's esophagus: results from the United States Radiofrequency Ablation Registry. Dis Esophagus. 2016;29:537-543. [PMID: 26121935 DOI: 10.1111/dote.12386] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
309 Furnari M, Telese A, Hann A, Lisotti A, Boškoski I, Eusebi LH. New Devices for Endoscopic Treatments in Gastroenterology: A Narrative Review. Curr Drug Metab 2020;21:850-65. [PMID: 32703127 DOI: 10.2174/1389200221666200722145727] [Reference Citation Analysis]
310 White JR, Ragunath K, Whitton A, Marsh E, Kaye P, Knight G. Study to investigate the prevalence of human papillomavirus in Barrett's oesophagus using a novel screening methodology. BMJ Open Gastroenterol 2022;9:e000840. [PMID: 35379652 DOI: 10.1136/bmjgast-2021-000840] [Reference Citation Analysis]
311 Offman J, Fitzgerald RC. Alternatives to Traditional Per-Oral Endoscopy for Screening. Gastrointest Endosc Clin N Am 2017;27:379-96. [PMID: 28577763 DOI: 10.1016/j.giec.2017.02.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
312 Semenkovich TR, Hudson JL, Subramanian M, Mullady DK, Meyers BF, Puri V, Kozower BD. Trends in Treatment of T1N0 Esophageal Cancer. Ann Surg 2019;270:434-43. [PMID: 31274653 DOI: 10.1097/SLA.0000000000003466] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 5.5] [Reference Citation Analysis]
313 Belghazi K, Pouw RE, Sondermeijer C, Meijer SL, Schoon EJ, Koch AD, Weusten B, Bergman J. A single-step sizing and radiofrequency ablation catheter for circumferential ablation of Barrett's esophagus: Results of a pilot study. United European Gastroenterol J 2018;6:990-9. [PMID: 30228886 DOI: 10.1177/2050640618768919] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
314 Bulsiewicz WJ, Kim HP, Dellon ES, Cotton CC, Pasricha S, Madanick RD, Spacek MB, Bream SE, Chen X, Orlando RC, Shaheen NJ. Safety and efficacy of endoscopic mucosal therapy with radiofrequency ablation for patients with neoplastic Barrett's esophagus. Clin Gastroenterol Hepatol. 2013;11:636-642. [PMID: 23103824 DOI: 10.1016/j.cgh.2012.10.028] [Cited by in Crossref: 73] [Cited by in F6Publishing: 59] [Article Influence: 7.3] [Reference Citation Analysis]
315 Weiner JP, Wong AT, Schwartz D, Martinez M, Aytaman A, Schreiber D. Endoscopic and non-endoscopic approaches for the management of radiation-induced rectal bleeding. World J Gastroenterol 2016; 22(31): 6972-6986 [PMID: 27610010 DOI: 10.3748/wjg.v22.i31.6972] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
316 Tsai TH, Zhou C, Lee HC, Tao YK, Ahsen OO, Figueiredo M, Adler DC, Schmitt JM, Huang Q, Fujimoto JG, Mashimo H. Comparison of Tissue Architectural Changes between Radiofrequency Ablation and Cryospray Ablation in Barrett's Esophagus Using Endoscopic Three-Dimensional Optical Coherence Tomography. Gastroenterol Res Pract 2012;2012:684832. [PMID: 22844274 DOI: 10.1155/2012/684832] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
317 Pech O. Endoscopic Treatment of Early Barrett's Neoplasia: Expanding Indications, New Challenges. Adv Exp Med Biol 2016;908:99-109. [PMID: 27573769 DOI: 10.1007/978-3-319-41388-4_6] [Reference Citation Analysis]
318 Vega KJ, May R, Sureban SM, Lightfoot SA, Qu D, Reed A, Weygant N, Ramanujam R, Souza R, Madhoun M. Identification of the putative intestinal stem cell marker doublecortin and CaM kinase-like-1 in Barrett’s esophagus and esophageal adenocarcinoma. J Gastroenterol Hepatol. 2012;27:773-780. [PMID: 21916995 DOI: 10.1111/j.1440-1746.2011.06928.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 46] [Article Influence: 3.9] [Reference Citation Analysis]
319 Frantzides CT, Carlson MA, Keshavarzian A, Roberts JE. Laparoscopic transgastric esophageal mucosal resection: 4-year minimum follow-up. Am J Surg 2010;200:305-7. [PMID: 20188346 DOI: 10.1016/j.amjsurg.2009.10.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
320 Wang WL, Chang IW, Chen CC, Chang CY, Tseng CH, Tai CM, Lin JT, Wang HP, Lee CT. The in vivo tissue effect of endoscopic balloon-based radiofrequency ablation in treating esophageal squamous cell neoplasia. United European Gastroenterol J 2018;6:656-61. [PMID: 30083326 DOI: 10.1177/2050640618755236] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
321 Trindade AJ, Raphael KL, Inamdar S, Stewart M, Berkowitz J, Vegesna A, McKinley MJ, Benias PC, Kahn A, Leggett CL, Lee C, Sejpal DV, Rishi A. Volumetric laser endomicroscopy features of dysplasia at the gastric cardia in Barrett's oesophagus: results from an observational cohort study. BMJ Open Gastroenterol 2019;6:e000340. [PMID: 31749979 DOI: 10.1136/bmjgast-2019-000340] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
322 Abbas G, Krasna M. Overview of esophageal cancer. Ann Cardiothorac Surg. 2017;6:131-136. [PMID: 28447001 DOI: 10.21037/acs.2017.03.03] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 11.2] [Reference Citation Analysis]
323 Adil MT, Al-Taan O, Rashid F, Munasinghe A, Jain V, Whitelaw D, Jambulingam P, Mahawar K. A Systematic Review and Meta-Analysis of the Effect of Roux-en-Y Gastric Bypass on Barrett's Esophagus. Obes Surg 2019;29:3712-21. [PMID: 31309524 DOI: 10.1007/s11695-019-04083-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
324 Bennett M, Mashimo H. Molecular markers and imaging tools to identify malignant potential in Barrett's esophagus. World J Gastrointest Pathophysiol 2014; 5(4): 438-449 [PMID: 25400987 DOI: 10.4291/wjgp.v5.i4.438] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
325 Max Almond L, Barr H. Management controversies in Barrett’s oesophagus. J Gastroenterol. 2013;Jun 5; Epub ahead of print. [PMID: 23736794 DOI: 10.1007/s00535-013-0816-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
326 Barr H, Almond M. The future developments in upper GI cancer. Frontline Gastroenterol 2012;3:i24-7. [PMID: 28839688 DOI: 10.1136/flgastro-2012-100113] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
327 Segal F, Breyer HP. Diagnosis and management of Barrett’s metaplasia: What’s new. World J Gastrointest Endosc 2012; 4(9): 379-386 [PMID: 23125895 DOI: 10.4253/wjge.v4.i9.379] [Reference Citation Analysis]
328 Sanghi V, Amin H, Sanaka MR, Thota PN. Resection of early esophageal neoplasms: The pendulum swings from surgical to endoscopic management. World J Gastrointest Endosc 2019; 11(10): 491-503 [PMID: 31798770 DOI: 10.4253/wjge.v11.i10.491] [Reference Citation Analysis]
329 Runge TM, Shaheen NJ, Djukic Z, Hallquist S, Orlando RC. Cleavage of E-Cadherin Contributes to Defective Barrier Function in Neosquamous Epithelium. Dig Dis Sci 2016;61:3169-75. [PMID: 27659669 DOI: 10.1007/s10620-016-4315-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
330 Quante M, Bhagat G, Abrams JA, Marache F, Good P, Lee MD, Lee Y, Friedman R, Asfaha S, Dubeykovskaya Z, Mahmood U, Figueiredo JL, Kitajewski J, Shawber C, Lightdale CJ, Rustgi AK, Wang TC. Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia. Cancer Cell. 2012;21:36-51. [PMID: 22264787 DOI: 10.1016/j.ccr.2011.12.004] [Cited by in Crossref: 280] [Cited by in F6Publishing: 249] [Article Influence: 28.0] [Reference Citation Analysis]
331 Lo WCY, Uribe-Patarroyo N, Hoebel K, Beaudette K, Villiger M, Nishioka NS, Vakoc BJ, Bouma BE. Balloon catheter-based radiofrequency ablation monitoring in porcine esophagus using optical coherence tomography. Biomed Opt Express 2019;10:2067-89. [PMID: 31086717 DOI: 10.1364/BOE.10.002067] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
332 Tuttle R, Nurkin SJ, Hochwald SN. Ablative therapy for esophageal dysplasia and early malignancy: focus on RFA. Biomed Res Int 2014;2014:642063. [PMID: 25140320 DOI: 10.1155/2014/642063] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
333 Shaheen NJ, Peery AF, Overholt BF, Lightdale CJ, Chak A, Wang KK, Hawes RH, Fleischer DE, Goldblum JR. Biopsy depth after radiofrequency ablation of dysplastic Barrett's esophagus. Gastrointestinal Endoscopy 2010;72:490-496.e1. [DOI: 10.1016/j.gie.2010.04.010] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
334 Wolf WA, Pasricha S, Cotton C, Li N, Triadafilopoulos G, Muthusamy VR, Chmielewski GW, Corbett FS, Camara DS, Lightdale CJ, Wolfsen H, Chang KJ, Overholt BF, Pruitt RE, Ertan A, Komanduri S, Infantolino A, Rothstein RI, Shaheen NJ. Incidence of Esophageal Adenocarcinoma and Causes of Mortality After Radiofrequency Ablation of Barrett's Esophagus. Gastroenterology 2015;149:1752-1761.e1. [PMID: 26327132 DOI: 10.1053/j.gastro.2015.08.048] [Cited by in F6Publishing: 39] [Reference Citation Analysis]
335 di Pietro M, Bird-Lieberman EL, Liu X, Nuckcheddy-Grant T, Bertani H, O'Donovan M, Fitzgerald RC. Autofluorescence-Directed Confocal Endomicroscopy in Combination With a Three-Biomarker Panel Can Inform Management Decisions in Barrett's Esophagus. Am J Gastroenterol. 2015;110:1549-1558. [PMID: 26416188 DOI: 10.1038/ajg.2015.295] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
336 Singh T, Sanaka MR, Thota PN. Endoscopic therapy for Barrett’s esophagus and early esophageal cancer: Where do we go from here? World J Gastrointest Endosc 2018; 10(9): 165-174 [PMID: 30283599 DOI: 10.4253/wjge.v10.i9.165] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
337 Hao J, Critchley-Thorne R, Diehl DL, Snyder SR. A Cost-Effectiveness Analysis Of An Adenocarcinoma Risk Prediction Multi-Biomarker Assay For Patients With Barrett's Esophagus. Clinicoecon Outcomes Res 2019;11:623-35. [PMID: 31749626 DOI: 10.2147/CEOR.S221741] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
338 Schmidt HM, Mohiuddin K, Bodnar AM, El Lakis M, Kaplan S, Irani S, Gan I, Ross A, Low DE. Multidisciplinary treatment of T1a adenocarcinoma in Barrett's esophagus: contemporary comparison of endoscopic and surgical treatment in physiologically fit patients. Surg Endosc 2016;30:3391-401. [PMID: 26541725 DOI: 10.1007/s00464-015-4621-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
339 Trindade AJ, Smith MS, Pleskow DK. The new kid on the block for advanced imaging in Barrett's esophagus: a review of volumetric laser endomicroscopy. Therap Adv Gastroenterol 2016;9:408-16. [PMID: 27134668 DOI: 10.1177/1756283X16639003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
340 Galey KM, Wilshire CL, Watson TJ, Schneider MD, Kaul V, Jones CE, Litle VR, Ullah A, Peters JH. Endoscopic management of early esophageal neoplasia: an emerging standard. J Gastrointest Surg 2011;15:1728-35. [PMID: 21811883 DOI: 10.1007/s11605-011-1618-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
341 Chennat J, Waxman I. Endoscopic treatment of Barrett’s esophagus: From metaplasia to intramucosal carcinoma. World J Gastroenterol 2010; 16(30): 3780-3785 [PMID: 20698040 DOI: 10.3748/wjg.v16.i30.3780] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
342 Luketich JD, Pennathur A, Franchetti Y, Catalano PJ, Swanson S, Sugarbaker DJ, De Hoyos A, Maddaus MA, Nguyen NT, Benson AB. Minimally invasive esophagectomy: results of a prospective phase II multicenter trial-the eastern cooperative oncology group (E2202) study. Ann Surg. 2015;261:702-707. [PMID: 25575253 DOI: 10.1097/sla.0000000000000993] [Cited by in Crossref: 105] [Cited by in F6Publishing: 41] [Article Influence: 15.0] [Reference Citation Analysis]
343 Low DE. Update on staging and surgical treatment options for esophageal cancer. J Gastrointest Surg 2011;15:719-29. [PMID: 21487832 DOI: 10.1007/s11605-011-1515-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
344 Ladabaum U. How I do it: Does this cost-effectiveness analysis convince me about screening for Barrett's esophagus? Gastrointest Endosc 2019;89:723-5. [PMID: 30902200 DOI: 10.1016/j.gie.2018.12.016] [Reference Citation Analysis]
345 Ahmed O, Ajani JA, Lee JH. Endoscopic management of esophageal cancer. World J Gastrointest Oncol 2019; 11(10): 830-841 [PMID: 31662822 DOI: 10.4251/wjgo.v11.i10.830] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
346 Hamel C, Ahmadzai N, Beck A, Thuku M, Skidmore B, Pussegoda K, Bjerre L, Chatterjee A, Dennis K, Ferri L, Maziak DE, Shea BJ, Hutton B, Little J, Moher D, Stevens A. Screening for esophageal adenocarcinoma and precancerous conditions (dysplasia and Barrett's esophagus) in patients with chronic gastroesophageal reflux disease with or without other risk factors: two systematic reviews and one overview of reviews to inform a guideline of the Canadian Task Force on Preventive Health Care (CTFPHC). Syst Rev 2020;9:20. [PMID: 31996261 DOI: 10.1186/s13643-020-1275-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
347 Matsuzaki J, Suzuki H, Asakura K, Saito Y, Hirata K, Takebayashi T, Hibi T. Gallstones increase the prevalence of Barrett's esophagus. J Gastroenterol 2010;45:171-8. [PMID: 19908109 DOI: 10.1007/s00535-009-0153-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
348 Bar N, Schwartz N, Nissim M, Fliss-Isacov N, Zelber-Sagi S, Kariv R. Barrett’s esophagus with high grade dysplasia is associated with non-esophageal cancer. World J Gastroenterol 2018; 24(39): 4472-4481 [PMID: 30356981 DOI: 10.3748/wjg.v24.i39.4472] [Reference Citation Analysis]
349 Tan WK, Rattan A, O'Donovan M, Nuckcheddy T, Alias B, Sujendran V, di Pietro M. Comparative outcomes of radiofrequency ablation for Barrett's oesophagus with different baseline histology. United European Gastroenterol J 2018;6:662-8. [PMID: 30083327 DOI: 10.1177/2050640617752183] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
350 Lenglinger J, Riegler FM. Selected Commentary to "Radiofrequency ablation in Barrett's esophagus with dysplasia": Shaheen NJ, Sharma P, Overholt BF, et al. N Engl J Med 2009;360:2277–88. Eur Surg 2009;41:132-5. [DOI: 10.1007/s10353-009-0470-0] [Reference Citation Analysis]
351 Almond LM, Old O, Barr H. Strategies for the prevention of oesophageal adenocarcinoma. Int J Surg 2014;12:931-5. [PMID: 25091397 DOI: 10.1016/j.ijsu.2014.07.273] [Reference Citation Analysis]
352 Tan WK, Ragunath K, White JR, Santiago J, Fernandez-Sordo JO, Pana M, Alias B, Hadjinicolaou AV, Sujendran V, di Pietro M. Standard versus simplified radiofrequency ablation protocol for Barrett's esophagus: comparative analysis of the whole treatment pathway. Endosc Int Open 2020;8:E189-95. [PMID: 32010753 DOI: 10.1055/a-1005-6331] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
353 Badylak SF, Hoppo T, Nieponice A, Gilbert TW, Davison JM, Jobe BA. Esophageal preservation in five male patients after endoscopic inner-layer circumferential resection in the setting of superficial cancer: a regenerative medicine approach with a biologic scaffold. Tissue Eng Part A. 2011;17:1643-1650. [PMID: 21306292 DOI: 10.1089/ten.tea.2010.0739] [Cited by in Crossref: 163] [Cited by in F6Publishing: 145] [Article Influence: 14.8] [Reference Citation Analysis]
354 Bertani H, Pigò F, Dabizzi E, Frazzoni M, Mirante VG, Manno M, Manta R, Conigliaro R. Advances in Endoscopic Visualization of Barrett's Esophagus: The Role of Confocal Laser Endomicroscopy. Gastroenterol Res Pract. 2012;2012:493961. [PMID: 22474437 DOI: 10.1155/2012/493961] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
355 Naveed M, Kubiliun N. Endoscopic Treatment of Early-Stage Esophageal Cancer. Curr Oncol Rep. 2018;20:71. [PMID: 30058019 DOI: 10.1007/s11912-018-0713-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
356 Eluri S, Brugge WR, Daglilar ES, Jackson SA, Styn MA, Callenberg KM, Welch DC, Barr TM, Duits LC, Bergman JJ. The Presence of Genetic Mutations at Key Loci Predicts Progression to Esophageal Adenocarcinoma in Barrett's Esophagus. Am J Gastroenterol. 2015;110:828-834. [PMID: 26010308 DOI: 10.1038/ajg.2015.152] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
357 Contino G, Vaughan TL, Whiteman D, Fitzgerald RC. The Evolving Genomic Landscape of Barrett's Esophagus and Esophageal Adenocarcinoma. Gastroenterology 2017;153:657-673.e1. [PMID: 28716721 DOI: 10.1053/j.gastro.2017.07.007] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 8.8] [Reference Citation Analysis]
358 Saunders MD, Nieponice A, Dvorak K, Goldman A, Diaz-Cervantes E, De-la-Torre-Bravo A, Sobrino-Cossio S, Torres-Durazo E, Martínez-Carrillo O, Gamboa-Robles J, Upton M, Appelman HD, Bonavina L, Rothstein RI, Velanovich V. Barrett's esophagus: endoscopic treatments I. Ann N Y Acad Sci 2011;1232:140-55. [PMID: 21950811 DOI: 10.1111/j.1749-6632.2011.06049.x] [Reference Citation Analysis]
359 Jankowski J, Barr H, Wang K, Delaney B. Diagnosis and management of Barrett's oesophagus. BMJ. 2010;341:c4551. [PMID: 20833742 DOI: 10.1136/bmj.c4551] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
360 Pesqué R, Percheron R, Cordonnier AL, Steelandt J, Paubel P, Pineau J, Prognon P, Martelli N. [Health technology assessment of innovative medical devices: Timing and decision at national and local level]. Ann Pharm Fr 2020;78:189-97. [PMID: 31806152 DOI: 10.1016/j.pharma.2019.10.002] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
361 Chang KJ. Endoscopic foregut surgery and interventions: The future is now. The state-of-the-art and my personal journey. World J Gastroenterol 2019; 25(1): 1-41 [PMID: 30643356 DOI: 10.3748/wjg.v25.i1.1] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
362 Parikh K, Khaitan L. Radiofrequency ablation coupled with Roux-en-Y gastric bypass: a treatment option for morbidly obese patients with Barrett's esophagus. J Surg Case Rep 2016;2016:rjw007. [PMID: 26945777 DOI: 10.1093/jscr/rjw007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
363 Tsai TH, Zhou C, Tao YK, Lee HC, Ahsen OO, Figueiredo M, Kirtane T, Adler DC, Schmitt JM, Huang Q, Fujimoto JG, Mashimo H. Structural markers observed with endoscopic 3-dimensional optical coherence tomography correlating with Barrett's esophagus radiofrequency ablation treatment response (with videos). Gastrointest Endosc. 2012;76:1104-1112. [PMID: 22831857 DOI: 10.1016/j.gie.2012.05.024] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 5.3] [Reference Citation Analysis]
364 Guccione C, Yadlapati R, Shah S, Knight R, Curtius K. Challenges in Determining the Role of Microbiome Evolution in Barrett's Esophagus and Progression to Esophageal Adenocarcinoma. Microorganisms 2021;9:2003. [PMID: 34683324 DOI: 10.3390/microorganisms9102003] [Reference Citation Analysis]
365 Amadi C, Gatenby P. Barrett’s oesophagus: Current controversies. World J Gastroenterol 2017; 23(28): 5051-5067 [PMID: 28811703 DOI: 10.3748/wjg.v23.i28.5051] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
366 Shaheen NJ, Kim HP, Bulsiewicz WJ, Lyday WD, Triadafilopoulos G, Wolfsen HC, Komanduri S, Chmielewski GW, Ertan A, Corbett FS, Camara DS, Rothstein RI, Overholt BF. Prior fundoplication does not improve safety or efficacy outcomes of radiofrequency ablation: results from the U.S. RFA Registry. J Gastrointest Surg 2013;17:21-8; discussion p.28-9. [PMID: 22965650 DOI: 10.1007/s11605-012-2001-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
367 Jansen M, Schölvinck DW, Kushima R, Sekine S, Weusten BL, Wang GQ, Fleischer DE, Yoshinaga S, Dawsey SM, Meijer SL, Bergman JJ, Oda I. Is it justified to ablate flat-type esophageal squamous cancer? An analysis of endoscopic submucosal dissection specimens of lesions meeting the selection criteria of radiofrequency studies. Gastrointest Endosc 2014;80:995-1002. [PMID: 25434658 DOI: 10.1016/j.gie.2014.09.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
368 Cotton CC, Duits LC, Wolf WA, Peery AF, Dellon ES, Bergman JJ, Shaheen NJ. Spatial predisposition of dysplasia in Barrett's esophagus segments: a pooled analysis of the SURF and AIM dysplasia trials. Am J Gastroenterol 2015;110:1412-9. [PMID: 26346864 DOI: 10.1038/ajg.2015.263] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
369 von Holzen U, Chen T, Boquoi A, Richter JE, Falk GW, Klein-Szanto AJ, Cooper H, Litwin S, Weinberg DS, Enders GH. Evidence for DNA damage checkpoint activation in barrett esophagus. Transl Oncol 2010;3:33-42. [PMID: 20165693 DOI: 10.1593/tlo.09187] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
370 Wilcox CM. Fiberoptic endoscopy: the singular transformative event of our time. Dig Dis Sci 2014;59:2619-22. [PMID: 25185659 DOI: 10.1007/s10620-014-3338-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
371 Nava HR, Allamaneni SS, Dougherty TJ, Cooper MT, Tan W, Wilding G, Henderson BW. Photodynamic therapy (PDT) using HPPH for the treatment of precancerous lesions associated with Barrett's esophagus. Lasers Surg Med 2011;43:705-12. [PMID: 22057498 DOI: 10.1002/lsm.21112] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
372 Shaheen NJ. Where is the finish line for endoscopic eradication therapy in Barrett's esophagus? Gastrointest Endosc 2019;89:926-8. [PMID: 31005132 DOI: 10.1016/j.gie.2019.01.017] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
373 Spechler SJ. Buried (but not dead) Barrett's metaplasia: tales from the crypts.Gastrointest Endosc. 2012;76:41-43. [PMID: 22726464 DOI: 10.1016/j.gie.2012.02.053] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
374 Gaddam S, Muthusamy R, Sharma P. The controversy regarding ablation for Barrett's esophagus without dysplasia. Curr Opin Gastroenterol 2011;27:368-73. [PMID: 21577102 DOI: 10.1097/MOG.0b013e328347bafc] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
375 Souza RF. Biomarkers in Barrett's Esophagus. Tech Gastrointest Endosc 2010;12:116-1212. [PMID: 20657812 DOI: 10.1016/j.tgie.2010.02.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
376 Beard DJ, Campbell MK, Blazeby JM, Carr AJ, Weijer C, Cuthbertson BH, Buchbinder R, Pinkney T, Bishop FL, Pugh J, Cousins S, Harris I, Lohmander LS, Blencowe N, Gillies K, Probst P, Brennan C, Cook A, Farrar-Hockley D, Savulescu J, Huxtable R, Rangan A, Tracey I, Brocklehurst P, Ferreira ML, Nicholl J, Reeves BC, Hamdy F, Rowley SC, Lee N, Cook JA. Placebo comparator group selection and use in surgical trials: the ASPIRE project including expert workshop. Health Technol Assess 2021;25:1-52. [PMID: 34505829 DOI: 10.3310/hta25530] [Reference Citation Analysis]
377 Thomas T, Ayaru L, Lee EY, Cirocco M, Kandel G, May G, Kortan P, Marcon NE. Length of Barrett's segment predicts success of extensive endomucosal resection for eradication of Barrett's esophagus with early neoplasia. Surg Endosc 2011;25:3627-35. [PMID: 21858582 DOI: 10.1007/s00464-011-1769-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
378 Subramanian CR, Triadafilopoulos G. Endoscopic treatments for dysplastic Barrett's esophagus: resection, ablation, what else? World J Surg 2015;39:597-605. [PMID: 24841804 DOI: 10.1007/s00268-014-2636-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
379 Krishnan K, Pandolfino JE, Kahrilas PJ, Keefer L, Boris L, Komanduri S. Increased risk for persistent intestinal metaplasia in patients with Barrett's esophagus and uncontrolled reflux exposure before radiofrequency ablation. Gastroenterology. 2012;143:576-581. [PMID: 22609385 DOI: 10.1053/j.gastro.2012.05.005] [Cited by in Crossref: 77] [Cited by in F6Publishing: 60] [Article Influence: 7.7] [Reference Citation Analysis]
380 Liu KSH, Wong IOL, Leung WK. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance. World J Gastroenterol 2016; 22(3): 1311-1320 [PMID: 26811668 DOI: 10.3748/wjg.v22.i3.1311] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
381 Nieto T, Tomlinson CL, Dretzke J, Bayliss S, Dilworth M, Beggs AD, Tucker O. Epigenetic biomarkers in progression from non-dysplastic Barrett's oesophagus to oesophageal adenocarcinoma: a systematic review protocol. BMJ Open 2016;6:e013361. [PMID: 27927666 DOI: 10.1136/bmjopen-2016-013361] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
382 Bonavina L. Selected commentary to review on novel concepts of columnar lined esophagus. Eur Surg 2014;46:96-7. [DOI: 10.1007/s10353-014-0260-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
383 Bang BW, Jeong S, Lee DH. Comparison of two porcine benign esophageal stricture models using radiofrequency ablation and endoscopic submucosal tunnel dissection. Turk J Gastroenterol 2018;29:502-8. [PMID: 30249567 DOI: 10.5152/tjg.2018.18046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
384 Dunn JM, Mackenzie GD, Oukrif D, Mosse CA, Banks MR, Thorpe S, Sasieni P, Bown SG, Novelli MR, Rabinovitch PS. Image cytometry accurately detects DNA ploidy abnormalities and predicts late relapse to high-grade dysplasia and adenocarcinoma in Barrett's oesophagus following photodynamic therapy. Br J Cancer. 2010;102:1608-1617. [PMID: 20461081 DOI: 10.1038/sj.bjc.6605688] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
385 Eluri S, Shaheen NJ. Barrett's esophagus: diagnosis and management. Gastrointest Endosc. 2017;85:889-903. [PMID: 28109913 DOI: 10.1016/j.gie.2017.01.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
386 Shimizu T, Samarasena JB, Fortinsky KJ, Hashimoto R, El Hage Chehade N, Chin MA, Moosvi Z, Chang KJ. Benefit, tolerance, and safety of hybrid argon plasma coagulation for treatment of Barrett's esophagus: US pilot study. Endosc Int Open 2021;9:E1870-6. [PMID: 34917455 DOI: 10.1055/a-1492-2450] [Reference Citation Analysis]
387 Malfertheiner MV, Kandulski A, Malfertheiner P, Schreiber J. [Bronchopulmonary manifestations of gastroesophageal reflux disease]. Internist (Berl) 2010;51 Suppl 1:246-54. [PMID: 20098976 DOI: 10.1007/s00108-009-2506-8] [Reference Citation Analysis]
388 Karamchandani DM, Lehman HL, Ohanessian SE, Massé J, Welsh PA, Odze RD, Goldblum JR, Berg AS, Stairs DB. Increasing diagnostic accuracy to grade dysplasia in Barrett's esophagus using an immunohistochemical panel for CDX2, p120ctn, c-Myc and Jagged1. Diagn Pathol 2016;11:23. [PMID: 26926447 DOI: 10.1186/s13000-016-0473-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
389 Dunn JM, Mackenzie GD, Banks MR, Mosse CA, Haidry R, Green S, Thorpe S, Rodriguez-Justo M, Winstanley A, Novelli MR. A randomised controlled trial of ALA vs. Photofrin photodynamic therapy for high-grade dysplasia arising in Barrett’s oesophagus. Lasers Med Sci. 2013;28:707-715. [PMID: 22699800 DOI: 10.1007/s10103-012-1132-1] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
390 Tan WK, di Pietro M, Fitzgerald RC. Past, present and future of Barrett's oesophagus. Eur J Surg Oncol 2017;43:1148-60. [PMID: 28256346 DOI: 10.1016/j.ejso.2017.02.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
391 Mansour NM, El-Serag HB, Anandasabapathy S. Barrett's esophagus: best practices for treatment and post-treatment surveillance. Ann Cardiothorac Surg 2017;6:75-87. [PMID: 28446996 DOI: 10.21037/acs.2017.03.05] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
392 Mizandari M, Kumar J, Pai M, Chikovani T, Azrumelashvili T, Reccia I, Habib N. Interventional radiofrequency ablation: A promising therapeutic modality in the management of malignant biliary and pancreatic duct obstruction. J Cancer 2018;9:629-37. [PMID: 29556320 DOI: 10.7150/jca.23280] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
393 Terry NG, Zhu Y, Rinehart MT, Brown WJ, Gebhart SC, Bright S, Carretta E, Ziefle CG, Panjehpour M, Galanko J. Detection of dysplasia in Barrett’s esophagus with in vivo depth-resolved nuclear morphology measurements. Gastroenterology. 2011;140:42-50. [PMID: 20854820 DOI: 10.1053/j.gastro.2010.09.008] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 4.7] [Reference Citation Analysis]
394 Condon A, Muthusamy VR. The evolution of endoscopic therapy for Barrett's esophagus. Ther Adv Gastrointest Endosc 2021;14:26317745211051834. [PMID: 34708204 DOI: 10.1177/26317745211051834] [Reference Citation Analysis]
395 Januszewicz W, Fitzgerald RC. Early detection and therapeutics. Mol Oncol. 2019;13:599-613. [PMID: 30677217 DOI: 10.1002/1878-0261.12458] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
396 Komanduri S, Kahrilas PJ, Krishnan K, McGorisk T, Bidari K, Grande D, Keefer L, Pandolfino J. Recurrence of Barrett's Esophagus is Rare Following Endoscopic Eradication Therapy Coupled With Effective Reflux Control. Am J Gastroenterol. 2017;112:556-566. [PMID: 28195178 DOI: 10.1038/ajg.2017.13] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 7.4] [Reference Citation Analysis]
397 Patel A, Gyawali CP. Screening for Barrett's Esophagus: Balancing Clinical Value and Cost-effectiveness. J Neurogastroenterol Motil 2019;25:181-8. [PMID: 30827080 DOI: 10.5056/jnm18156] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
398 Haidry R, Lovat L, Sharma P. Radiofrequency ablation for Barrett's dysplasia: past, present and the future? Curr Gastroenterol Rep 2015;17:13. [PMID: 25740248 DOI: 10.1007/s11894-015-0433-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
399 Smyth EC, Lagergren J, Fitzgerald RC, Lordick F, Shah MA, Lagergren P, Cunningham D. Oesophageal cancer. Nat Rev Dis Primers. 2017;3:17048. [PMID: 28748917 DOI: 10.1038/nrdp.2017.48] [Cited by in Crossref: 249] [Cited by in F6Publishing: 246] [Article Influence: 49.8] [Reference Citation Analysis]
400 Nieto T, Tomlinson CL, Dretzke J, Bayliss S, Price MJ, Dilworth M, Beggs AD, Tucker O. A systematic review of epigenetic biomarkers in progression from non-dysplastic Barrett's oesophagus to oesophageal adenocarcinoma. BMJ Open 2018;8:e020427. [PMID: 29961009 DOI: 10.1136/bmjopen-2017-020427] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
401 Gray NA, Odze RD, Spechler SJ. Buried metaplasia after endoscopic ablation of Barrett's esophagus: a systematic review. Am J Gastroenterol. 2011;106:1899-908; quiz 1909. [PMID: 21826111 DOI: 10.1038/ajg.2011.255] [Cited by in Crossref: 133] [Cited by in F6Publishing: 107] [Article Influence: 12.1] [Reference Citation Analysis]
402 Krishnamoorthi R, Singh S, Ragunathan K, A Katzka D, K Wang K, G Iyer P. Risk of recurrence of Barrett's esophagus after successful endoscopic therapy. Gastrointest Endosc. 2016;83:1090-1106.e3. [PMID: 26902843 DOI: 10.1016/j.gie.2016.02.009] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 8.7] [Reference Citation Analysis]
403 Diaz LI, Mony S, Klapman J. Narrative review of the role of gastroenterologist in the diagnosis, treatment and palliation in gastric and gastroesophageal cancer. Ann Transl Med 2020;8:1106. [PMID: 33145325 DOI: 10.21037/atm-20-4143] [Reference Citation Analysis]
404 Tsai TH, Fujimoto JG, Mashimo H. Endoscopic Optical Coherence Tomography for Clinical Gastroenterology.Diagnostics (Basel). 2014;4:57-93. [PMID: 26852678 DOI: 10.3390/diagnostics4020057] [Cited by in Crossref: 53] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
405 Luckett T, Allamneni C, Cowley K, Eick J, Gullick A, Peter S. Length of Barrett's segment predicts failure of eradication in radiofrequency ablation for Barrett's esophagus: a retrospective cohort study. BMC Gastroenterol 2018;18:67. [PMID: 29783927 DOI: 10.1186/s12876-018-0799-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
406 Koutsoumpas A, Wang LM, Bailey AA, Gillies R, Marshall R, Booth M, Sgromo B, Maynard N, Braden B. Non-radical, stepwise complete endoscopic resection of Barrett's epithelium in short segment Barrett's esophagus has a low stricture rate. Endosc Int Open 2016;4:E1292-7. [PMID: 27995191 DOI: 10.1055/s-0042-118282] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
407 Zakko L, Lutzke L, Wang KK. Screening and Preventive Strategies in Esophagogastric Cancer. Surg Oncol Clin N Am 2017;26:163-78. [PMID: 28279462 DOI: 10.1016/j.soc.2016.10.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
408 Veitch A, Rutter M. Improving quality in endoscopy: are we nearly there yet? Frontline Gastroenterol 2015;6:127-31. [PMID: 28839799 DOI: 10.1136/flgastro-2015-100564] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
409 Kristo I, Schoppmann S, Riegler M, Püspök A, Emmanuel K, Spaun G, Wrba F, Wenzl E, Schöfl R, Schreiber F, Häfner M, Madl C. Austrian expert panel recommendation for radiofrequency ablation of Barrett’s esophagus. Eur Surg 2015;47:319-23. [DOI: 10.1007/s10353-015-0362-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
410 Singh A, Chak A. Advances in the management of Barrett's esophagus and early esophageal adenocarcinoma. Gastroenterol Rep (Oxf). 2015;3:303-315. [PMID: 26486568 DOI: 10.1093/gastro/gov048] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
411 Qumseya B. Barrett esophagus: Current standards and future directions. Techniques in Gastrointestinal Endoscopy 2018;20:53-4. [DOI: 10.1016/j.tgie.2018.04.001] [Reference Citation Analysis]
412 Qumseya BJ, Wani S, Gendy S, Harnke B, Bergman JJ, Wolfsen H. Disease Progression in Barrett's Low-Grade Dysplasia With Radiofrequency Ablation Compared With Surveillance: Systematic Review and Meta-Analysis. Am J Gastroenterol. 2017;112:849-865. [PMID: 28374819 DOI: 10.1038/ajg.2017.70] [Cited by in Crossref: 45] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
413 Milashka M, Calomme A, Van Laethem JL, Blero D, Eisendrath P, Le Moine O, Devière J. Sixteen-year follow-up of Barrett's esophagus, endoscopically treated with argon plasma coagulation. United European Gastroenterol J 2014;2:367-73. [PMID: 25360314 DOI: 10.1177/2050640614549095] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
414 Golger D, Probst A, Messmann H. Barrett's esophagus: lessons from recent clinical trials. Ann Gastroenterol 2016;29:417-23. [PMID: 27708506 DOI: 10.20524/aog.2016.0070] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
415 Falk GW. Update on ablation for Barrett's esophagus. Curr Gastroenterol Rep 2014;16:368. [PMID: 24357349 DOI: 10.1007/s11894-013-0368-7] [Reference Citation Analysis]
416 Gatenby P, Bhattacharjee S, Wall C, Caygill C, Watson A. Risk stratification for malignant progression in Barrett’s esophagus: Gender, age, duration and year of surveillance. World J Gastroenterol 2016; 22(48): 10592-10600 [PMID: 28082811 DOI: 10.3748/wjg.v22.i48.10592] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
417 Ganz RA. Corrections regarding endotherapy for Barrett's esophagus. Am J Gastroenterol 2012;107:1756-7; author reply 1757-8. [PMID: 23160298 DOI: 10.1038/ajg.2012.308] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
418 Cotton CC, Wolf WA, Overholt BF, Li N, Lightdale CJ, Wolfsen HC, Pasricha S, Wang KK, Shaheen NJ; AIM Dysplasia Trial Group. Late Recurrence of Barrett's Esophagus After Complete Eradication of Intestinal Metaplasia is Rare: Final Report From Ablation in Intestinal Metaplasia Containing Dysplasia Trial. Gastroenterology 2017;153:681-688.e2. [PMID: 28579538 DOI: 10.1053/j.gastro.2017.05.044] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 10.4] [Reference Citation Analysis]
419 Karamchandani DM, Zhang Q, Liao XY, Xu JH, Liu XL. Inflammatory bowel disease- and Barrett's esophagus-associated neoplasia: the old, the new, and the persistent struggles. Gastroenterol Rep (Oxf) 2019;7:379-95. [PMID: 31857901 DOI: 10.1093/gastro/goz032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
420 Sreenarasimhaiah J. Endoscopic applications of cryospray ablation therapy-from Barrett’s esophagus and beyond. World J Gastrointest Endosc 2016; 8(16): 546-552 [PMID: 27621766 DOI: 10.4253/wjge.v8.i16.546] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
421 Baretton GB, Aust DE. [Barrett's esophagus. An update]. Pathologe. 2012;33:5-16. [PMID: 22293785 DOI: 10.1007/s00292-011-1541-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
422 Dąbrowski WP, Szczepanik AB, Misiak A, Pielaciński K. Radiofrequency ablation in the management of Barrett's esophagus - preliminary own experience. Wideochir Inne Tech Maloinwazyjne 2013;8:107-11. [PMID: 23837094 DOI: 10.5114/wiitm.2011.32807] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
423 Han S, Wani S. Quality Indicators in Endoscopic Ablation for Barrett's Esophagus. Curr Treat Options Gastroenterol 2017;15:241-55. [PMID: 28421454 DOI: 10.1007/s11938-017-0136-0] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
424 Gupta M, Iyer PG, Lutzke L, Gorospe EC, Abrams JA, Falk GW, Ginsberg GG, Rustgi AK, Lightdale CJ, Wang TC, Fudman DI, Poneros JM, Wang KK. Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett's esophagus: results from a US Multicenter Consortium. Gastroenterology. 2013;145:79-86.e1. [PMID: 23499759 DOI: 10.1053/j.gastro.2013.03.008] [Cited by in Crossref: 160] [Cited by in F6Publishing: 135] [Article Influence: 17.8] [Reference Citation Analysis]